HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).HIV Seropositivity: Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).HIV Seroprevalence: Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY).HIV-1: The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.HIV Seronegativity: Immune status consisting of non-production of HIV antibodies, as determined by various serological tests.Anti-HIV Agents: Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.AIDS Serodiagnosis: Immunologic tests for identification of HIV (HTLV-III/LAV) antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX.HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.Sexual Behavior: Sexual activities of humans.CD4 Lymphocyte Count: The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.Homosexuality, Male: Sexual attraction or relationship between males.Risk-Taking: Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her.Anti-Retroviral Agents: Agents used to treat RETROVIRIDAE INFECTIONS.Viral Load: The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.Substance Abuse, Intravenous: Abuse, overuse, or misuse of a substance by its injection into a vein.AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.Prevalence: The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.South Africa: A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria (administrative), Cape Town (legislative), and Bloemfontein (judicial). Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960.Antiretroviral Therapy, Highly Active: Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.Sexual Partners: Married or single individuals who share sexual relations.HIV Antigens: Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.CD4-Positive T-Lymphocytes: A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.AIDS Dementia Complex: A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)Prostitution: The practice of indulging in sexual relations for money.Zimbabwe: A republic in southern Africa, east of ZAMBIA and BOTSWANA and west of MOZAMBIQUE. Its capital is Harare. It was formerly called Rhodesia and Southern Rhodesia.HIV Protease Inhibitors: Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly.Condoms: A sheath that is worn over the penis during sexual behavior in order to prevent pregnancy or spread of sexually transmitted disease.HIV Core Protein p24: A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.Homosexuality: The sexual attraction or relationship between members of the same SEX.Infectious Disease Transmission, Vertical: The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding.Unsafe Sex: Sexual behaviors which are high-risk for contracting SEXUALLY TRANSMITTED DISEASES or for producing PREGNANCY.Cross-Sectional Studies: Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.Uganda: A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala.Syphilis: A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.Pregnancy Complications, Infectious: The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.Heterosexuality: The sexual attraction or relationship between members of the opposite SEX.HIV Antibodies: Antibodies reactive with HIV ANTIGENS.HIV Envelope Protein gp120: External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV.Africa South of the Sahara: All of Africa except Northern Africa (AFRICA, NORTHERN).Malawi: A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland.Coinfection: Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.Cohort Studies: Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.AIDS-Related Complex: A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS.United StatesHIV Wasting Syndrome: Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611).Counseling: The giving of advice and assistance to individuals with educational or personal problems.Circumcision, Male: Excision of the prepuce of the penis (FORESKIN) or part of it.Receptors, HIV: Cellular receptors that bind the human immunodeficiency virus that causes AIDS. Included are CD4 ANTIGENS, found on T4 lymphocytes, and monocytes/macrophages, which bind to the HIV ENVELOPE PROTEIN GP120.Safe Sex: Sexual behavior that prevents or reduces the spread of SEXUALLY TRANSMITTED DISEASES or PREGNANCY.Health Knowledge, Attitudes, Practice: Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL).Virus Replication: The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.RNA, Viral: Ribonucleic acid that makes up the genetic material of viruses.Receptors, CCR5: CCR receptors with specificity for CHEMOKINE CCL3; CHEMOKINE CCL4; and CHEMOKINE CCL5. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; MAST CELLS; and NK CELLS. The CCR5 receptor is used by the HUMAN IMMUNODEFICIENCY VIRUS to infect cells.Sexually Transmitted Diseases: Diseases due to or propagated by sexual contact.Incidence: The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.Voluntary Programs: Programs in which participation is not required.Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.Zidovudine: A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.Epidemics: Sudden outbreaks of a disease in a country or region not previously recognized in that area, or a rapid increase in the number of new cases of a previous existing endemic disease. Epidemics can also refer to outbreaks of disease in animal or plant populations.HIV-2: An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker.Population Surveillance: Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.HIV Reverse Transcriptase: A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process.HIV Long-Term Survivors: Persons who have experienced prolonged survival of HIV infection. This includes the full spectrum of untreated, HIV-infected long-term asymptomatics to those with AIDS who have survived due to successful treatment.Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.Substance-Related Disorders: Disorders related to substance abuse.Zambia: A republic in southern Africa, south of DEMOCRATIC REPUBLIC OF THE CONGO and TANZANIA, and north of ZIMBABWE. Its capital is Lusaka. It was formerly called Northern Rhodesia.Mass Screening: Organized periodic procedures performed on large groups of people for the purpose of detecting disease.Tanzania: A republic in eastern Africa, south of UGANDA and north of MOZAMBIQUE. Its capital is Dar es Salaam. It was formed in 1964 by a merger of the countries of TANGANYIKA and ZANZIBAR.HIV Enteropathy: A syndrome characterized by chronic, well-established DIARRHEA (greater than one month in duration) without an identified infectious cause after thorough evaluation, in an HIV-positive individual. It is thought to be due to direct or indirect effects of HIV on the enteric mucosa. HIV enteropathy is a diagnosis of exclusion and can be made only after other forms of diarrheal illness have been ruled out. (Harrison's Principles of Internal Medicine, 13th ed, pp1607-8; Haubrich et al., Bockus Gastroenterology, 5th ed, p1155)Needle Sharing: Usage of a single needle among two or more people for injecting drugs. Needle sharing is a high-risk behavior for contracting infectious disease.Antigens, CD4: 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120.Sex Workers: People who engage in occupational sexual behavior in exchange for economic rewards or other extrinsic considerations.Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.Sexually Transmitted Diseases, Viral: Viral diseases which are transmitted or propagated by sexual conduct.CD8-Positive T-Lymphocytes: A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.HIV Protease: Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene.PrisonersIndiaKenya: A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi.Rural Population: The inhabitants of rural areas or of small towns classified as rural.Centers for Disease Control and Prevention (U.S.): An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries.Rwanda: A republic in eastern Africa, south of UGANDA, east of DEMOCRATIC REPUBLIC OF THE CONGO, west of TANZANIA. Its capital is Kigali. It was formerly part of the Belgian trust territory of Ruanda-Urund.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Viremia: The presence of viruses in the blood.Disease Progression: The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.Socioeconomic Factors: Social and economic factors that characterize the individual or group within the social structure.Simian Acquired Immunodeficiency Syndrome: Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS.Drug Resistance, Viral: The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation.New York CityLogistic Models: Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.AfricaTime Factors: Elements of limited time intervals, contributing to particular results or situations.Organophosphonates: Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.Infant, Newborn: An infant during the first month after birth.Simian immunodeficiency virus: Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV.Crack Cocaine: The purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested. Use of crack results in alterations in function of the cardiovascular system, the autonomic nervous system, the central nervous system, and the gastrointestinal system. The slang term "crack" was derived from the crackling sound made upon igniting of this form of cocaine for smoking.Reverse Transcriptase Inhibitors: Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Drug Users: People who take drugs for a non-therapeutic or non-medical effect. The drugs may be legal or illegal, but their use often results in adverse medical, legal, or social consequences for the users.Prisons: Penal institutions, or places of confinement for war prisoners.Patient Acceptance of Health Care: The seeking and acceptance by patients of health service.Lymphoma, AIDS-Related: B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including BURKITT LYMPHOMA; IMMUNOBLASTIC LARGE-CELL LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; and DIFFUSE, LARGE B-CELL, LYMPHOMA. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.San FranciscoAIDS Vaccines: Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.HIV Envelope Protein gp41: Transmembrane envelope protein of the HUMAN IMMUNODEFICIENCY VIRUS which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in CELL FUSION with the CD4 ANTIGENS of T4 LYMPHOCYTES, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by IMMUNOBLOTTING.Multivariate Analysis: A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.Developing Countries: Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.Ethiopia: An independent state in eastern Africa. Ethiopia is located in the Horn of Africa and is bordered on the north and northeast by Eritrea, on the east by Djibouti and Somalia, on the south by Kenya, and on the west and southwest by Sudan. Its capital is Addis Ababa.Antitubercular Agents: Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.Urban Population: The inhabitants of a city or town, including metropolitan areas and suburban areas.CD4-CD8 Ratio: Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.Cameroon: A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC and west of NIGERIA. The capital is Yaounde.AIDS-Associated Nephropathy: Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Contact Tracing: Identification of those persons (or animals) who have had such an association with an infected person, animal, or contaminated environment as to have had the opportunity to acquire the infection. Contact tracing is a generally accepted method for the control of sexually transmitted diseases.China: A country spanning from central Asia to the Pacific Ocean.Thailand: Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city.Social Stigma: A perceived attribute that is deeply discrediting and is considered to be a violation of social norms.Interviews as Topic: Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.Case-Control Studies: Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.HIV Fusion Inhibitors: Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS.Leukocytes, Mononuclear: Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules.Disease Transmission, Infectious: The transmission of infectious disease or pathogens. When transmission is within the same species, the mode can be horizontal or vertical (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).Lymphocyte Activation: Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.British Columbia: A province of Canada on the Pacific coast. Its capital is Victoria. The name given in 1858 derives from the Columbia River which was named by the American captain Robert Gray for his ship Columbia which in turn was named for Columbus. (From Webster's New Geographical Dictionary, 1988, p178 & Room, Brewer's Dictionary of Names, 1992, p81-2)Risk Reduction Behavior: Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.Swaziland: A kingdom in southern Africa, west of MOZAMBIQUE. Its capital is Mbabane. The area was settled by the Swazi branch of the Zulu nation in the early 1880's, with its independence guaranteed by the British and Transvaal governments in 1881 and 1884. With limited self-government introduced in 1962, it became independent in 1968. Swazi is the Zulu name for the people who call themselves Swati, from Mswati, the name of a 16th century king, from a word meaning stick or rod. (From Webster's New Geographical Dictionary, 1988, p1170 & Room, Brewer's Dictionary of Names, 1992, p527)Ambulatory Care Facilities: Those facilities which administer health services to individuals who do not require hospitalization or institutionalization.Comorbidity: The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.Age Factors: Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.Health Education: Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis.Transients and Migrants: People who frequently change their place of residence.United States Health Resources and Services Administration: A component of the PUBLIC HEALTH SERVICE that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training.Mozambique: A republic in southern Africa, south of TANZANIA, east of ZAMBIA and ZIMBABWE, bordered on the west by the Indian Ocean. Its capital is Maputo. It was formerly called Portuguese East Africa.African Americans: Persons living in the United States having origins in any of the black groups of Africa.Anonymous Testing: Testing in which the source of the specimen or the person being tested is not individually identified.Adenine: A purine base and a fundamental unit of ADENINE NUCLEOTIDES.Needle-Exchange Programs: Organized services for exchange of sterile needles and syringes used for injections as a potential means of reducing the transmission of infectious diseases.Blood DonorsNamibia: A republic in southern Africa, south of ANGOLA and west of BOTSWANA. Its capital is Windhoek.Stereotyping: An oversimplified perception or conception especially of persons, social groups, etc.Seroepidemiologic Studies: EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.HIV-Associated Lipodystrophy Syndrome: Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.HIV Integrase Inhibitors: Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA.T-Lymphocytes: Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Receptors, CXCR4: CXCR receptors with specificity for CXCL12 CHEMOKINE. The receptors may play a role in HEMATOPOIESIS regulation and can also function as coreceptors for the HUMAN IMMUNODEFICIENCY VIRUS.Puerto Rico: An island in the Greater Antilles in the West Indies. Its capital is San Juan. It is a self-governing commonwealth in union with the United States. It was discovered by Columbus in 1493 but no colonization was attempted until 1508. It belonged to Spain until ceded to the United States in 1898. It became a commonwealth with autonomy in internal affairs in 1952. Columbus named the island San Juan for St. John's Day, the Monday he arrived, and the bay Puerto Rico, rich harbor. The island became Puerto Rico officially in 1932. (From Webster's New Geographical Dictionary, 1988, p987 & Room, Brewer's Dictionary of Names, 1992, p436)World Health: The concept pertaining to the health status of inhabitants of the world.Hispanic Americans: Persons living in the United States of Mexican (MEXICAN AMERICANS), Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin. The concept does not include Brazilian Americans or Portuguese Americans.Antiviral Agents: Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.tat Gene Products, Human Immunodeficiency Virus: Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS.Ulcer: A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.Longitudinal Studies: Studies in which variables relating to an individual or group of individuals are assessed over a period of time.Cells, Cultured: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.Harm Reduction: The application of methods designed to reduce the risk of harm associated with certain behaviors without reduction in frequency of those behaviors. The risk-associated behaviors include ongoing and active addictive behaviors.Vaginal Douching: The washing of the VAGINA cavity or surface with a solution. Agents or drugs can be added to the irrigation solution.Delayed Diagnosis: Non-optimal interval of time between onset of symptoms, identification, and initiation of treatment.Urban Health: The status of health in urban populations.Enzyme-Linked Immunosorbent Assay: An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.Communicable Disease Control: Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.Sarcoma, Kaposi: A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.Sentinel Surveillance: Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in a larger population. (From Last, Dictionary of Epidemiology, 2d ed)Demography: Statistical interpretation and description of a population with reference to distribution, composition, or structure.Truth Disclosure: Truthful revelation of information, specifically when the information disclosed is likely to be psychologically painful ("bad news") to the recipient (e.g., revelation to a patient or a patient's family of the patient's DIAGNOSIS or PROGNOSIS) or embarrassing to the teller (e.g., revelation of medical errors).Cote d'Ivoire: A republic in western Africa, south of MALI and BURKINA FASO, bordered by GHANA on the east. Its administrative capital is Abidjan and Yamoussoukro has been the official capital since 1983. The country was formerly called Ivory Coast.Emigration and Immigration: The process of leaving one's country to establish residence in a foreign country.Administration, Intravaginal: The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.Sex Factors: Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.Ritonavir: An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. It also inhibits CYTOCHROME P-450 CYP3A.DNA, Viral: Deoxyribonucleic acid that makes up the genetic material of viruses.Patient Compliance: Voluntary cooperation of the patient in following a prescribed regimen.BrazilHaiti: A republic in the Greater Antilles in the West Indies. Its capital is Port-au-Prince. With the Dominican Republic it forms the island of Hispaniola - Haiti occupying the western third and the Dominican Republic, the eastern two thirds. Haiti belonged to France from 1697 until its rule was challenged by slave insurrections from 1791. It became a republic in 1820. It was virtually an American protectorate from 1915 to 1934. It adopted its present constitution in 1964 and amended it in 1971. The name may represent either of two Caribbean words, haiti, mountain land, or jhaiti, nest. (From Webster's New Geographical Dictionary, 1988, p481 & Room, Brewer's Dictionary of Names, 1992, p225)Attitude to Health: Public attitudes toward health, disease, and the medical care system.Medication Adherence: Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.Lesotho: A kingdom in southern Africa, within the republic of SOUTH AFRICA. Its capital is Maseru.Risk Assessment: The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.Nigeria: A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja.Immunocompromised Host: A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.Drug Therapy, Combination: Therapy with two or more separate preparations given for a combined effect.Candidiasis, Oral: Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)Herpesvirus 2, Human: A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Mouth DiseasesDisease Outbreaks: Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.Contraceptive Devices, Male: Contraceptive devices used by males.Botswana: A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest.Transgendered Persons: Persons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one's anatomical sex at birth, and with or without a desire to undergo SEX REASSIGNMENT PROCEDURES.LondonHealth Services Accessibility: The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others.Los AngelesLymphocyte Count: The number of LYMPHOCYTES per unit volume of BLOOD.Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)Odds Ratio: The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.Rape: Unlawful sexual intercourse without consent of the victim.

*  Medical Xpress - hiv infection
Medical Xpress - hiv infection. Home. Conditions. Hiv Infection. Hiv Infection. sort by:. Date. ... 1 month. all. HIV & AIDS. Videos reveal how HIV spreads ... 02, 2015 116 3. HIV & AIDS. UN: HIV patients should start ... model shows infection's sci-fi-worthy creep into the brain ... Medical Xpress - hiv infection. Hiv Infection. Hiv Infection. HIV & AIDS. HIV & AIDS. HIV & AIDS. Medical research. Medical research. Diseases, Conditions, Syndromes. Diseases, Conditions, Syndromes. HIV & AIDS. A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system's killer T cells. HIV & AIDS. HIV & AIDS. Researchers have found a promising way of kicking the AIDS virus out of its hiding place in infected cells, potentially removing the main obstacle to curing HIV. HIV & AIDS. Researchers at Michigan State University were part of a team to discover a new natural defense against HIV infection. W...
http://medicalxpress.com/conditions/hiv-infection/sort/rank/1d/
*  AIDSinfo | Information on HIV/AIDS Treatment, Prevention and Research
Information on HIV/AIDS Treatment, Prevention and Research ... Management of HIV Complications. Adult and Adolescent OI ... Disaster Displaced HIV-Infected Patients. Guidelines on Care ... Search by Category Choose a Topic Cancer Coinfections Complications/Side Effects FDA-Approved HIV Drugs FDA-Approved Opportunistic Infection and Coinfection Drugs Investigational HIV Drugs Opportunistic Infections Prevention Research Specific Populations Treatment Research Trials by Age Trials by Study Type Vaccine Research. Search HIV/AIDS Drugs....
https://aidsinfo.nih.gov/
*  NATAP Conference Reports - 2000
the latest in HIV and AIDS drug research and treatment ... and Opportunistic Infections conference, as well as from the ICAR, ... and International HIV and AIDS conferences, and from other ... NATAP Conference Reports - 2000. The National AIDS Treatment Advocacy Project - NATAP - provides the latest in HIV and AIDS drug research and treatment information as well as comprehensive reports and developments from the Fifth Retroviruses and Opportunistic Infections conference, as well as from the ICAR, ICAAC, IDSA, European and International HIV and AIDS conferences, and from other sources. Jules Levin Reports Live from the. American Association for the Study of Liver Diseases 51th Annual Meeting, Dallas,. Selected Reports from the 5th International Congress on Drug Therapy in HIV Infection in Glasgow, Scotland. Selected Reports from The ICAAC Conference in Toronto. Selected Reports from The Lipodystrophy Workshop in Toronto: 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Select...
http://natap.org/oldconferences/00cnfr.htm
*  Physician's Weekly for Medical News, Opinions & Articles
Tivicay for HIV Infection ... Physician s Weekly for Medical News, Opinions Articles. HOME ARTICLES BY TOPIC BLOG RECENT FEATURES CME. Continue Reading. Continue Reading. Continue Reading. Continue Reading. In 2014, the American College of Cardiology and American Heart Association ACC/AHA released an updated guideline on perioperative cardiovascular evaluation and management of patients undergoing non-cardiac surgery. Continue Reading. Many general surgery residents seriously consider leaving residency, with women being more likely to consider such action than men. Continue Reading. Surgery: Things Left Behind. FDA Approves Vibativ for Hospitalized Patients With Bacterial Pneumonia. FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer. 10 Signs of Child Trafficking in Medical Care Developing a Cardiology-Oncology Partnership The Cult of Dr. ICAAC 2015. Continue Reading >. VIEW ALL. VIEW ALL. VIEW ALL. “Arrrr, matey I wish we had better healthcare options, too.”... VIEW ALL. Medical Artic...
http://physiciansweekly.com/
*  More Progress from Baby “Functionally Cured” of HIV Infection
Cured of HIV Infection. Nav Top Menu. Baltimore News ... More Progress from Baby Functionally Cured of HIV Infection. Baltimore News Washington D.C. News Prince George s County News About Afro. Afro Your Community. Your News. National News. Baltimore News. Prince George s County News. Washington. Washington D.C. News. Health. Tweets from https://twitter.com/afronewslive/lists/afronewslive. Tabs Widget National News National News. Tabs Widget Washington D.C. NEWS Washington D.C. NEWS. Tabs Widget Baltimore News Baltimore News. Tabs Widget Prince George's County News Prince George's County News. 1 October 2015 Prince George’s County Cpl. More Progress from Baby Functionally Cured of HIV Infection More Progress from Baby Functionally Cured of HIV Infection. The child was delivered premature at 35 weeks to a mother that had no documented prenatal care or treatment for the HIV-1 virus, for which she tested positive while in labor. The big question, of course, is, Is the child cured of HIV infection. Hammer, who...
http://afro.com/sections/news/health/story.htm/?storyid=80198
*  Pharmaceutical Companies Working to Develop CCR5 Inhibitor Drugs to Treat HIV Infection - TheBody.co
Drugs to Treat HIV Infection - TheBody.com. . Advertisement. 0 ... Drugs to Treat HIV Infection From Henry J. Kaiser Family ... that would prevent HIV from entering human cells rather than ... Pharmaceutical Companies Working to Develop CCR5 Inhibitor Drugs to Treat HIV Infection - TheBody.com. Medical News Pharmaceutical Companies Working to Develop CCR5 Inhibitor Drugs to Treat HIV Infection From Henry J. Kaiser Family Foundation. February 18, 2005 Several pharmaceutical companies are "racing" to bring to market a new class of antiretroviral drugs, called CCR5 inhibitors, that would prevent HIV from entering human cells rather than fighting the virus once it has entered cells, Reuters reports Hirschler, Reuters, 2/16. The Pfizer compound has entered Phase III trials Kaiser Daily HIV/AIDS Report, 1/6. Graeme Moyle, an HIV expert at the Chelsea and Westminster Hospital in London, said, "We need these drugs," adding, "We have downsides with the medications we have at present in terms of toxicity, in ter...
http://thebody.com/content/art9274.html
*  4th Intl Conference on Nutrition and HIV Infection
on Nutrition and HIV Infection. Report for NATAP from the ... on Nutrition and HIV Infection Second European Workshop on ... associated with HIV cause lipoatrophy. He discusses ... More recently, the Prometheus study and a second Abbott study, both looking at dual protease inhibitor therapy, demonstrated, importantly, that lipoatrophy or fat wasting can occur in individuals who have never received, or are not currently receiving nucleoside analogue therapy, the chance of developing lipoatrophy during follow-up is markedly increased when both nucleoside analogues and protease inhibitors are combined together. Drawing upon data presented by Dr Walker, he outlined that the levels of mitochondrial DNA depletion observed in fat biopsies are much more modest relative to those observed in familial mitochondrial diseases and that some individuals in lipoatrophy have normal mitochondrial DNA, whilst some control patients without lipoatrophy have depleted quantities of mitochondrial DNA. Drugs which may be used ...
http://natap.org/2001/apr/4th_icni042701.htm
*  WHO | Pre-exposure prophylaxis
Play Store. HIV/AIDS. Menu. HIV News and events ... the acquisition of HIV infection by uninfected persons. PrEP ... for treatment of HIV infection tenofovir plus emtricitabine ... Pre-exposure prophylaxis. Health topics. Media centre. Play Store. HIV/AIDS. HIV News and events Topics Publications Data and statistics About us. Pre-exposure prophylaxis. Pre-exposure prophylaxis or PrEP is the use of an antiretroviral medication to prevent the acquisition of HIV infection by uninfected persons. PrEP may either be taken orally, using an antiretroviral drug available for treatment of HIV infection tenofovir plus emtricitabine, or topically as a vaginal gel containing tenofovir. September 2015 Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. July 2015 PrEP implementation science: state-of-the-art and research agenda Supplement - JIAS Journal of the International AIDS Society. July 2015 Oral pre-exposure prophylaxis: putting a new choice in context Publication produc...
http://who.int/hiv/topics/prep/en/
*  HIV Surveillance: Epidemiology of HIV Infection (Through 2011) - TheBody.com
HIV Surveillance: Epidemiology of HIV Infection Through 2011 - TheBody.com. 0. Advertisement. 0 Email. . ... hiv surveillance epidemiology of hiv infection through thebody com advertisement email...
http://thebody.com/content/66399/hiv-surveillance-epidemiology-of-hiv-infection-th.html
*  Burning Penis Sign Of HIV Infection - The Body
Penis Sign Of HIV Infection - The Body. Skip to main content. ... links. TOPICS IN HIV/AIDS. Ask The Experts. Search. ... Reminder Service HIV Care Professionals The Body en Espanol ... ...to get HIV tested is HIV-exposure risk, whether or...
http://thebody.com/h/burning-penis-sign-of-HIV-infection.html
*  Nutritional recovery in HIV-infected and HIV-uninfected children with severe acute malnutrition -
... UCL Discovery. UCL Discovery. UCL home » Library Services » Electronic resources » UCL Discovery Enter your search terms. UCL Theses. About UCL Discovery. Nutritional recovery in HIV-infected and HIV-uninfected children with severe acute malnutrition. Nutritional recovery in HIV-infected and HIV-uninfected children with severe acute malnutrition. This study explores nutritional recovery in HIV-infected and HIV-uninfected children during inpatient nutrition rehabilitation and 4 months of follow-up.Design: Prospective cohort study.Setting: Lilongwe district, Malawi.Main outcome measures: Weight gain, anthropometrics.Results: In our sample of 454 children with severe acute malnutrition SAM, 17.4% n = 79 of children were HIV infected. Among the HIV-infected children, 35.4% 28/79 died, compared with 10.4% 39/375 in HIV-uninfected children p 0.001. All children who survived achieved nutritional recovery 85% weight for height and no oedema, regardless of HIV status. HIV-infected children had similar weight gain...
http://discovery.ucl.ac.uk/125133/
*  Asymptomatic HIV infection Medical Information
... All Consumer Professional Pill ID Interactions News FDA Alerts Approvals Pipeline Clinical Trials Care Notes Encyclopedia Dictionary Natural Products. Asymptomatic HIV infection. Asymptomatic HIV infection Asymptomatic HIV infection is a phase of chronic infection with human immunodeficiency virus HIV during which there are no symptoms of HIV infection. Causes of Asymptomatic HIV infection. Asymptomatic HIV infection is phase in which the immune system in someone with HIV slowly deteriorates, but the person has no symptoms. Asymptomatic HIV infection Symptoms. Asymptomatic HIV means a person does not have symptoms typically seen in people with HIV. A diagnosis of HIV infection is based on results from blood tests, including the HIV antibody test ELISA. Treatment of Asymptomatic HIV infection. When a person without symptoms of AIDs should receive therapy remains controversial. Those who do not have symptoms but who have CD4 lymphocyte counts of less than 350 should receive anti-viral treatment. This thera...
http://drugs.com/enc/asymptomatic-hiv-infection.html
*  Bacteremia in Human Immunodeficiency Virus-infected Children... : The Pediatric Infectious Diseas
... e Journal. Advertisement. Enter your Email address:. Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. The Pediatric Infectious Disease Journal Wolters Kluwer Health Logo. Subscribe. Search Jobs. Saved Searches. Recent Searches. You currently have no recent searches. Login. Register. Activate Subscription. eTOC. Help. All Issues Current Issue Issue Displayed. Advanced Search. Home Currently selected. Current Issue. Previous Issues. Published Ahead-of-Print. Collections. For Authors. Information for Authors. Language Editing Services. Journal Info. About the Journal. Editorial Board. Affiliated Societies. Advertising. Open Access. Subscription Services. Reprints. Rights and Permissions. Mobile. New Features. iPad App. Home. October 2011 - Volume 30 - Issue 10. Bacteremia in Human Immunodeficiency Virus-infecte...
http://journals.lww.com/pidj/Abstract/2011/10000/Bacteremia_in_Human_Immunodeficiency.23.aspx
*  SCHERING-PLOUGH PRESENTS CLINICAL DATA ON CCR5 RECEPTOR ANTAGONIST AT 9TH CONFERENCE ON RETROVIRUSES
... AND OPPORTUNISTIC INFECTIONS. Conference Reports for NATAP. 9th Conference on Retroviruses and Opportunistic Infections   Seattle, Washington, February, 2002. Back  . SCHERING-PLOUGH PRESENTS CLINICAL DATA ON CCR5 RECEPTOR ANTAGONIST AT 9TH CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS. Following yesterday's oral presentation by a researcher from Schering Plough, Mark Laughlin, about their entry inhibitor for HIV, Schering issued this statement which I feel you'd like to read. Schering-Plough Research Institute today presented preliminary clinical data on its CCR5 receptor antagonist, a novel therapeutic approach in the treatment of HIV infection, at the 9th Conference on Retroviruses and Opportunistic Infections in Seattle. In an oral presentation at the conference's opening session on new antiretroviral agents, Mark M. Laughlin, M.D., director, clinical pharmacology, Schering-Plough Research Institute, presented clinical results showing a direct antiviral effect in patients in fected ...
http://natap.org/2002/9retro/day2.htm
*  Infectious Disease Clinics of North America Journal Impact Factor & Description - ResearchGate
Infectious Disease Clinics of North America Journal Impact Factor Description - ResearchGate. Infectious Disease Clinics of North America INFECT DIS CLIN N AM Publisher: WB Saunders Journal description Each issue of Infectious Disease Clinics reviews new diagnostic and management techniques for a single clinical problem--and makes them simple to apply. Infectious Disease Clinics website. Other titles Infectious disease clinics of North America, Infectious disease clinics. Auwaerter Infectious Disease Clinics of North America 06/2015; 29 2. DOI:10.1016/S0891-5520 15 00034-3. Clostridium difficile Infection. Wilcox Infectious Disease Clinics of North America 03/2015; 29 1. DOI:10.1016/S0891-5520 15 00009-4. ABSTRACT: Clostridium difficile infection CDI is the most common cause of infectious health care-associated diarrhea and is a major burden to patients and the health care system. Copyright © 2015 Elsevier Inc. All rights reserved. Infectious Disease Clinics of North America 03/2015; 29 1 :123-134. DOI:10.101...
http://researchgate.net/journal/0891-5520_Infectious_Disease_Clinics_of_North_America
*  JAMA | Antiretroviral Treatment of Adult HIV Infection2012 Recommendations of the International A
JAMA. Antiretroviral Treatment of Adult HIV Infection2012 Recommendations of the International Antiviral Society–USA Panel. Sign in via Shibboleth. Create an Account. The JAMA Network. JAMA The Journal of the American Medical Association. JAMA Surgery. You've earned it free CME tokens, redeemable for CME Credits, have been added to your personal account courtesy of The JAMA Network and. Antiretroviral Treatment of Adult HIV Infection : 2012 Recommendations of the International Antiviral Society–USA Panel Melanie A. doi:10.1001/jama.2012.7961. • Sign in to your personal account • Institutional sign in: Athens. October 17, 2012 Treatment of Human Immunodeficiency Virus in Adults Tom A. • Sign in to your personal account • Institutional sign in: Athens. Return to: Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel. Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel. • Sign in to...
http://jama.jamanetwork.com/article.aspx?articleid=1221704&atab=7
*  Highlights of the 5th Conference on Retroviruses and Opportunistic Infections - TheBody.com
... Advertisement. 0 Email. Print-Friendly. Glossary. Editorial Highlights of the 5th Conference on Retroviruses and Opportunistic Infections What Are the Newest Developments in the Treatment of HIV. How Will These Advances Affect You. An Advocate for People Living With HIV Provides a Full Report By Dawn Averitt From San Francisco General Hospital. April 1998 A note from TheBody.com: The field of medicine is constantly evolving. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information. The Conference on Retroviruses and Opportunistic Infections, which attracts more than 3,000 experts on HIV disease from around the globe, has come to be regarded as the most important scientific meeting of the year for those involved in AIDS research. The particular strength of this annual meeting is that it brings together researchers who rarely venture outside their laboratories and office-based physicians who have never seen the in...
http://thebody.com/content/art12708.html?nxtprv
*  The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug u
... sers: A long-term retrospective cohort study. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study. Eighty HIV-positive and 80 HIV-negative injection drug users included between 1980 and 1995 were matched according to age, gender, and duration of HCV infection and followed-up during 52 months. High serum HCV-RNA level was associated with low CD4-lymphocyte count P = .001. The progression to cirrhosis was accelerated in HIV-positive patients with low CD4 cell count RR = 4.06, P = .024 and in interferon-untreated patients RR = 4.76, P = .001, independently of age at HCV infection P = .001. In this retrospective cohort study, HIV coinfection worsened the outcome of chronic hepatitis C, increasing both serum HCV-RNA level and liver damage and decreasing sustained response to interferon therapy. 1 to compare the virologic and histologic characteristics of chronic hepatitis C in HIV-positive and HIV-negative injection dr...
http://natap.org/2001/hepc/121001_1.htm
*  Abacavir and Myocardial Infarction Risk: Additional Data
... The question of whether abacavir increases the risk of myocardial infarction MI initially arose with a study from the D:A:D cohort last year, followed by conflicting analyses from other studies see previous HMQ reports Abacavir and Didanosine Associated with Increased Risk of Myocardial Infarction and Abacavir and Risk of Myocardial Infarction: The SMART Study. A case-control study from the French Hospital Database found that current or recent abacavir use was associated with MI risk odds ratio: 1.97, but only for subjects who had been on abacavir 1 year in patients on abacavir >1 year, or in those with past use of abacavir, there was no statistically significant increased risk of MI. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal. In: Program and abstracts of the 16th Conference on Retroviruses and ...
http://hivinsite.ucsf.edu/insite?page=hmq-0905-06
*  Hepatitis C Virus and Human Immunodeficiency Virus Coinfection in an Urban Population: Low Eligibili
... ty for Interferon Treatment. Articles. Back  . Hepatitis C Virus and Human Immunodeficiency Virus Coinfection in an Urban Population: Low Eligibility for Interferon Treatment. One hundred eighty human immunodeficiency virus HIV and hepatitis C virus HCV coinfected patients were prospectively evaluated for suitability for interferon and ribavirin therapy. Of the 149 patients with chronic HCV infection who completed the evaluation, 44 30% were eligible for treatment and 105 70% were ineligible, with the main barriers being missed clinic visits, active psychiatric illness, active drug or alcohol use, decompensated liver disease, or medical illness.. These barriers persisted despite ongoing education regarding the seriousness of HCV disease and access to a designated psychiatrist and substance abuse programs ..... These data underscore the challenges that exist in treating HCV disease in an urban population of HCV- and HIV-coinfected patients. Of interest, 14% of the patients referred were HCV RNA negativ...
http://natap.org/2003/Jan/012403_2.htm
*  Meeting the Behavioural Data Collection Needs of National HIV/AIDS and STD Programmes (Implementing
Meeting the Behavioural Data Collection Needs of National HIV/AIDS and STD Programmes Implementing AIDS Prevention and Care Project - Joint United Nations Programme on HIV/AIDS - United States Agency for International Development, 1998, 41 p. Sustaining behavioural data collection over time. HOME HELP PREFERENCES. Search Titles Subjects Organizations. EXPAND TEXT. EXPAND CONTENTS. DETACH. NO HIGHLIGHTING. Meeting the Behavioural Data Collection Needs of National HIV/AIDS and STD Programmes Implementing AIDS Prevention and Care Project - Joint United Nations Programme on HIV/AIDS - United States Agency for International Development, 1998, 41 p. introduction... 1 Introduction. 2 Why track behaviour. 3 Linking behavioural data with HIV serosurveillance. 4 What is needed to understand and track behaviour. 5 Do people tell the truth about their sexual and drug-taking behaviour. 6 Recommended mix of data collection methods. 7 What next. 8 Sustaining behavioural data collection over time. Bibliography. Annex. 8 Sust...
http://nzdl.org/gsdlmod?e=d-00000-00---off-0aedl--00-0----0-10-0---0---0direct-10---4-------0-1l--11-en-50---20-help---00-0-1-00-0--4----0-0-11-10-0utfZz-8-00&a=d&c=aedl&cl=CL3.30&d=HASHb0ab7655d451df28d95d51.9
*  Asymptomatic HIV Infection Symptoms & Treatment, NE - CHI Health, Omaha
... Asymptomatic HIV infection Definition Asymptomatic HIV infection is a phase of chronic infection with human immunodeficiency virus HIV during which there are no symptoms of HIV infection. Causes Asymptomatic HIV infection is phase in which the immune system in someone with HIV slowly deteriorates, but the person has no symptoms. Symptoms Asymptomatic HIV means a person does not have symptoms typically seen in people with HIV. A diagnosis of HIV infection is based on results from blood tests, including the HIV antibody test ELISA. Possible Complications People with asymptomatic infection can progress to symptomatic HIV infection, develop opportunistic infections associated with HIV, and transmit HIV to other people. People at risk for HIV infection should have regular testing to ensure early diagnosis of this infection, as many treatment options are available. Treatment of human immunodeficiency virus infection and acquired immunodeficiency syndrome. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard...
http://chihealth.com/body.cfm?id=3218&action=detail&AEArticleID=000682&AEProductID=Adam2004_117&AEProjectTypeIDURL=APT_1
*  PLOS ONE: Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Pat
... ients on Antiretroviral Therapy. Article-Level Metrics. Click through the PLOS taxonomy to find articles in your field. View. Sum of PLOS and PubMed Central page views and downloads. Open Access Peer-reviewed Research Article. Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy. Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy Abraham M. Published: January 2, 2013 DOI: 10.1371/journal.pone.0053022. Article. This cohort study utilized data from a large HIV treatment program in western Kenya to describe the impact of active tuberculosis TB on clinical outcomes among African patients on antiretroviral therapy ART. 2013 Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy. For purposes of this analysis, patients were categorized into 3 groups based on their CD4 cell count at ART initiation: 1 CD4 50 c...
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0053022
*  Women's Interagency HIV Study (WIHS)
Women's Interagency HIV Study WIHS. Library. E-mail. Contact Us. HIV Center for Women and Children. Patient Care and Services. AIDS Education and Training Center. HIV/ID Seminar Series. NYS International Training Research Program NYS-ITRP. HIV Track / Medicine Residency Program. HIV Track / PA Program. Counseling. Supportive Counseling Services. Patient Care. Medical Support for Adults. Medical Support for Adolescents. WIHS. Treatment of HIV/AIDS. Women Specific. Other Community Services. Birnbaum, MD, MPH. Howard Crystal, MD. DeHovitz, MD, MPH. Howard Minkoff, MD. Yusuff, MD, MPH. Seminar Series. Employment. NYS International Training Research Program NYS-ITRP. STAR Health Center. HIV Center for Women and Children. Women's Interagency HIV Study WIHS Women's Interagency HIV Study WIHS Funded by the National Institutes of Health for over 20 years, the multicenter Women's Interagency HIV Study WIHS is the largest and longest-running study to investigate the impact of HIV on women in the United States. Findings ...
http://downstate.edu/hiv/WIHS.html
*  hivandhepatitis.com - CROI 2013: Women's PrEP Trial Does Not Show HIV Risk Reduction [VIDEO] | HIV P
hivandhepatitis.com - CROI 2013: Women's PrEP Trial Does Not Show HIV Risk Reduction. HIV Prevention. hivandhepatitis.com. HIV/AIDS HIV/AIDS Topics HIV Prevention. HIV Disease Progression. HIV Testing Diagnosis. Hepatitis B Hepatitis B Topics HBV Treatment. HBV Disease Progression. HBV Prevention. HBV Testing Diagnosis. HIV/Hepatitis Coinfection HIV/HBV Coinfection. HIV/AIDS HIV/AIDS Topics. HIV Prevention CROI 2013: Women's PrEP Trial Does Not Show HIV Risk Reduction. CROI 2013: Women's PrEP Trial Does Not Show HIV Risk Reduction Details Category: HIV Prevention. Long-awaited results from the VOICE trial of post-exposure prophylaxis PrEP for women in Africa, presented at the recent 20th Conference on Retroviruses and Opportunistic Infections CROI 2013 in Atlanta, was not able to show that daily oral tenofovir plus emtricitabine the drugs in Truvada could lower the risk of HIV acquisition. As previously described in a report by Gus Cairns, VOICE randomly assigned more than 5000 women in South Africa, Uganda, ...
http://hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-prevention/4049-croi-2013-womens-prep-trial-does-show-hiv-risk-reduction-video
*  hivandhepatitis.com - Pegylated Interferon May Maintain HIV Suppression and Reduce Viral DNA Integra
... tion. hivandhepatitis.com. HIV/AIDS HIV/AIDS Topics HIV Prevention. HIV Disease Progression. HIV Testing Diagnosis. Hepatitis B Hepatitis B Topics HBV Treatment. HBV Disease Progression. HBV Populations. HBV Prevention. HBV Testing Diagnosis. HIV/Hepatitis Coinfection HIV/HBV Coinfection. Search for a Cure Pegylated Interferon May Maintain HIV Suppression and Reduce Viral DNA Integration. Pegylated Interferon May Maintain HIV Suppression and Reduce Viral DNA Integration Details Category: Search for a Cure. Adding pegylated interferon alfa to antiretroviral therapy ART for HIV may help some people control viral replication when they interrupt treatment, according to a small study reported at this year's Conference on Retroviruses and Opportunistic Infections CROI 2012 and published in the October 26, 2012, advance online edition of the Journal of Infectious Diseases. Results At 12 weeks, 9 of 20 participants 45% who stayed on pegylated interferon monotherapy maintained viral suppression 400 copies/mL. ...
http://hivandhepatitis.com/hiv-treatment/hiv-cure/3859-pegylated-interferon-may-maintain-hiv-suppression-and-reduce-viral-dna-integratio
*  U.S. National HIV/AIDS Strategy Release Is Imminent - TheBody.com
u s national hiv aids strategy release is imminent thebody com print this page back to web version of article u s national hiv aids strategy release is imminent by olivia ford june finally the release of the u s s first ever national hiv aids strategy is almost upon us we re no longer talking months we re talking weeks said u s office of national aids policy director jeffrey crowley in a conference call with community members on june organizations across the u s are circling the wagons preparing to alert their constituencies about the strategy upon its release since back in the days when onap convened a dozen plus open meetings in different cities and communities across the u s in order to document what people had to say about what should be included in the nation s first national hiv aids strategy they ve attempted to keep the community abreast of what they re up to as far as developing the strategy updating their own blog and that of aids gov releasing a shiny report including photos on the results of the m...
http://thebody.com/content/art57089.html?ts=pf
*  The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk - Full Text View - Clinical
... Trials.gov. Find Studies Study Record Detail. The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk This study has been completed. Sponsor: University of California, San Francisco Collaborator: GlaxoSmithKline Information provided by Responsible Party : University of California, San Francisco. ClinicalTrials.gov Identifier: NCT01333644 First received: March 1, 2011 Last updated: May 29, 2015 Last verified: May 2015 History of Changes. Just as these changes are thought be causally associated with heart disease in the very old,the investigators postulate that these changes will be associated with early heart disease in the untreated and perhaps treated HIV disease. HIV Infection Cardiovascular Disease Inflammation. Official Title: The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk. Further study details as provided by University of California, San Francisco:. HIV-Infection Treated HIV-infected individuals with an undetectable HIV RNA level 75 copies RNA/mL, untreated...
https://clinicaltrials.gov/ct2/show/NCT01333644?term=" February 16, 2011":" March 18, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]&rank=5
*  POZ Exclusives
A Smart + Strong Site. ABOUT HIV/AIDS. What is HIV/AIDS. Back to home » POZ Exclusives March 31, 2010. March 25, 2010. March 16, 2010. March 10, 2010. March 09, 2010. HIV and the Brain: Part 2 At the 17th Conference on Retroviruses and Opportunistic Infections CROI in San Francisco David Evans speaks with Scott Letendre, MD, from the University of California in San Diego, about the relationship of HIV levels in the brain versus the blood, and what that might mean for treating HIV. New Treatments for HIV: Part 1 At the 17th Conference on Retroviruses and Opportunistic Infections CROI in San Francisco Tim Horn speaks with David Hardy, MD, from Cedars Sinai Medical Center in Los Angeles, about new HIV treatments including the drug blood level-booster, cobicistat, and the new integrase inhibitor, elvitegravir. New Treatments for HIV: Part 2 At the 17th Conference on Retroviruses and Opportunistic Infections CROI in San Francisco Tim Horn speaks with David Hardy, MD, from Cedars Sinai Medical Center in Los Angeles...
http://poz.com/archive/March_2010_401.shtml
*  .. Roundup: HIV Infection Rate Among Young Blacks “Alarming”, Abortion Returns
infection rate. · · · · ·. Abortion. Roundup: HIV Infection Rate Among Young Blacks “Alarming”, Abortion Returns to Spotlight. by Brady Swenson, RH Reality Check. September 12, 2008 - 10:00 am. CDC calls HIV infection rate for young black men “alarming”; Abortion has returned to the glaring spotlight of the 2008 election; Judge rejects abortion related anti-Obama group’s request for FEC injunction. · · · · ·. McCain, Obama Respond to New Numbers on HIV Infection Rate. by Julie Davids, CHAMP. August 5, 2008 - 7:00 am. In response to new numbers suggesting that the HIV infection rate in the U.S. is 40% higher than previously reported, Barack Obama called for a national HIV plan while John McCain failed to call for a national, coordinated strategy. · · · · ·....
http://rhrealitycheck.org/tag/infection-rate/
*  42 U.S. Code § 300ff–87a - National HIV/AIDS testing goal | LII / Legal Information Institute
Code § 300ff–87a - National HIV/AIDS testing goal. Code § 300ff–87a - National HIV/AIDS testing goal. a In general Not later than January 1, 2010, the Secretary shall establish a national HIV/AIDS testing goal of 5,000,000 tests for HIV/AIDS annually through federally-supported HIV/AIDS prevention, treatment, and care programs, including programs under this subchapter and other programs administered by the Centers for Disease Control and Prevention. 2 the total number of individuals tested through federally-supported and other HIV/AIDS prevention, treatment, and care programs in each State;. B through federally-supported and other HIV/AIDS prevention, treatment, and care programs, were diagnosed and referred into treatment and care during such period;. 5 the amount of funding the Secretary determines necessary to meet the annual testing goal in the following 12 months and the amount of Federal funding expended to meet the testing goal in the prior 12-month period; and. c Review of program effectiveness Not la...
https://law.cornell.edu/uscode/text/42/300ff-87a?quicktabs_8=0
*  Role of Therapeutic Drug Monitoring in Management of Pediatric HIV Infection | Pediatric ARV Guideli
Role of Therapeutic Drug Monitoring in Management of Pediatric HIV Infection. Search HIV/AIDS Drugs. Role of Therapeutic Drug Monitoring in Management of Pediatric HIV Infection. Adherence to Antiretroviral Therapy in HIV-Infected Children and Adolescents. Role of Therapeutic Drug Monitoring in Management of Pediatric HIV Infection. Please send your comments with the subject line Comments on Pediatric ARV Guidelines to ContactUs@aidsinfo.nih.gov by March 20, 2015. Evaluation of plasma concentrations of antiretroviral drugs is not required in the management of most pediatric patients with HIV, but should be considered in children on combination antiretroviral therapy in the following scenarios BII : Use of antiretroviral drugs with limited pharmacokinetic data and therapeutic experience in children e.g., for use of efavirenz in children aged 3 years and darunavir with once-daily dosing in children aged 12 years ; Significant drug-drug interactions and food-drug interactions; Unexpected suboptimal treatment res...
https://aidsinfo.nih.gov/guidelines/html/2/pediatric-arv-guidelines/108/role-of-therapeutic-drug-monitoring-in-management-of-treatment-failure
*  Opinion : Implementing the National HIV/AIDS Strategy Across the United States - by Grant Colfax
... A Smart + Strong Site. POZ STORIES. POZ 100. NEWLY DIAGNOSED. ABOUT HIV/AIDS. What is HIV/AIDS. Newsfeed Treatment News POZ Exclusives Opinion Criminalization News Conference Coverage Global News World AIDS Day RSS Feeds. March 29, 2013 Implementing the National HIV/AIDS Strategy Across the United States. by Grant Colfax. Successful implementation of the National HIV/AIDS Strategy the Strategy requires ongoing collaboration among federal, state, and local governments and key non-governmental stakeholders. As part of our ongoing efforts to support Strategy implementation, ONAP is convening community discussions across the United States. moving people from an HIV diagnosis to care, treatment, and viral suppression The importance of the Affordable Care Act implementation for HIV care and prevention. At each meeting, state and local public health officials, representatives from community-based organizations, advocates, and other key stakeholders convene. ONAP and other federal partners provide information ab...
http://poz.com/articles/grant_colfax_2676_23732.shtml?commentson=no
*  Antiretroviral Drugs May Halt HIV Spread in Heterosexuals --Doctors Lounge
... Search Symptoms. Medical Reference. Drugs. Back to Journal Articles Antiretroviral Drugs May Halt HIV Spread in Heterosexuals. Studies find that daily use may prevent HIV acquisition in unaffected heterosexuals. A daily oral dose of antiretroviral drugs used for the treatment of HIV infection may reduce HIV acquisition among uninfected individuals exposed to the virus through heterosexual sex, according to the results of a new U.S. Centers for Disease Control and Prevention study, the TDF2 study, along with the results of a separate trial Partners Pre-Exposure Prophylaxis study. WEDNESDAY, July 13 HealthDay News -- A daily oral dose of antiretroviral drugs used for the treatment of HIV infection may reduce HIV acquisition among uninfected individuals exposed to the virus through heterosexual sex, according to the results of a new U.S. Centers for Disease Control and Prevention study, the TDF2 study, along with the results of a separate trial Partners Pre-Exposure Prophylaxis study. In the TDF2 study, 1,2...
http://doctorslounge.com/index.php/news/pb/21595
*  DermIS - HIV-Infection (information on the diagnosis)
dermis hiv infection information on the diagnosis doia pedoia information modules organisations user input info related doia same page in doia differential diagnoses infectious mononucleosis secondary lues chronic recurrent aphthae drug eruption related links search www google com for hiv infection search string by alphabet a b c d e f g h i j k l m n o p q r s t u v w x y z by localization hiv infection definition includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity through aids related complex arc to acquired immunodeficiency syndrome aids synonyms hiv infection umls hiv disease human immunodeficiency virus disease unspecified hiv disease unspecified human immunodeficiency virus disease hiv human immunodeficiency virus infection hiv disease hiv infection hiv infections htlv ...
http://dermis.net/dermisroot/en/11088/diagnosep.htm
*  UAB - SOM - Women's Interagency HIV Study. - Home
UAB - SOM - Women's Interagency HIV Study. Home About WIHS Participant Information Investigator Resources Getting to WIHS Contact Us. Enroll Today We are currently looking for 100 culturally and ethnically diversity women from Alabama and Mississippi who have HIV or at risk for HIV. If you choose to enroll in this study, you will be asked to provide data through:. Whether you are HIV positive or negative, the data you will provide will help increase scientific knowledge of HIV and its effect on the women's body. As an HIV negative participant, you data will be used to compare with the scientific finds gained from our HIV positive participants. Also you involvement in this study will provide you will knowledge of how HIV affects your own body through acquiring knowledge of you internal, gynecological and physical health. That's why every WIHS participant is so important. About WIHS The Women's Interagency HIV Study, WIHS, began in 1993 to investigate the impact of HIV infection on women in the United States. s...
http://assistive.usablenet.com/tt/uab.edu/medicine/wihs/
*  Is Itchy Skin A Sign Of Acute HIV Infection - The Body
. Is Itchy Skin A Sign Of Acute HIV Infection - The Body. Skip to main content. Skip page links. TOPICS IN HIV/AIDS. Ask The Experts. Search. Search. Follow Us. Facebook. Twitter. Newsletters. Search. Search. THEBODY.COM. What's New Newsletters Android/iPhone App My Health Tracker Personal Reminder Service HIV Care Professionals The Body en Espanol ASOFinder.com. Ask The Experts. TOPICS IN HIV/AIDS. Treatment. HIV Medications. Hepatitis C Coinfection. GI Issues. Other Side Effects Coinfections. Drug Resistance. Switching Stopping Treatment. Pediatric HIV Treatment. Prevention. HIV/AID Basics. HIV Prevention. HIV Testing. Safer Sex. Other Sexually Transmitted Diseases. Myths About HIV/AIDS. History of the AIDS Epidemic. Immune System Basics. Helping Friends With HIV/AIDS. Living With HIV. Getting Good Care. Healthy Living With HIV. Arts, Media HIV/AIDS. Diet, Nutrition HIV/AIDS. HIV Stigma. Relationships, Sexuality HIV/AIDS. Vitamins, Minerals Supplements. HIV and Financial Issues. HIV and Legal Issues. Person...
http://thebody.com/h/is-itchy-skin-a-sign-of-acute-HIV-infection.html
*  Infectious Disease Clinic | Stanford Health Care
Infectious Disease Clinic. Stanford Health Care. For Health Care Professionals. Stanford Health Care SHC formerly Stanford Hospital & Clinics. Infectious Disease Clinic. Infectious Disease Clinic. Our team of infectious disease doctors have specialized expertise in many areas, including: General infectious diseases Infections related to immunodeficiency Travel medicine and tropical diseases HIV and sexually transmitted diseases Bone and joint infections Infections associated with cystic fibrosis. Montoya, Infectious disease doctor, Infectious disease doctor. Care and Treatment of Infectious Diseases. Stanford Health Care's infectious diseases clinics provide state-to-the-art diagnosis and treatment for patients with various kinds of infections. We have over 10 clinic doctors with highly specialized expertise at the following Bay Area clinics: General Infectious Diseases Clinic Treats infections of different etiologies and of different organ systems, from bacterial pneumonia, Clostridium difficile colitis C. O...
https://stanfordhealthcare.org/medical-clinics/infectious-disease-clinic.html
*  HPV in Adolescents - Full Text View - ClinicalTrials.gov
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration Collaborators: Thai Red Cross AIDS Research Centre Chulalongkorn University South East Asia Research Collaboration with Hawaii We Understand Group TREAT Asia Information provided by Responsible Party : The HIV Netherlands Australia Thailand Research Collaboration. This study will assess the prevalence of HPV infection in perinatally HIV-infected adolescents, intraepithelial neoplasia, and E6E7 biomarker at cervical and anal sites. Further study details as provided by The HIV Netherlands Australia Thailand Research Collaboration:. Primary Outcome Measures: HPV infection Prevalence of cervical and anal HPV infection and of oncogenic subtypes, among perinatally HIV-infected adolescents, behaviorally HIV-infected adolescents, and HIv-negative adolescents. Perinatally HIV-infected adolescents Perinatally HIV-infected adolescents. behaviorally HIV-infected adolescents behaviorally HIV-infected adolescents. HIV negative adolescents HIV negative a...
https://clinicaltrials.gov/show/NCT01788852?order=233
*  Reducing the HIV infection rate
Re: Reducing the HIV infection rate Reply #100 on: December 04, 2008, 07:34:59 PM. Logged Aug 07 Diagnosed Oct 07 CD4=446 19% Feb 08 CD4=421 19% Jun 08 CD4=325 22% Jul 08 CD4=301 18% Sep 08 CD4=257/VL=75,000 Oct 08 CD4=347 16% Dec 08 CD4=270 16% Jan 09 CD4=246 13% /VL=10,000 Feb 09 CD4=233 15% /VL=13,000 Started meds Sustiva/Epzicom May 09 CD4=333 24% /VL=650 Aug 09 CD4=346 24% /VL=UD Nov 09 CD4=437 26% /VL=UD Feb 10 CD4=471 31% /VL=UD June 10 CD4=517 28% /VL=UD Sept 10 CD4=687 31% /VL=UD Jan 11 CD4=557 30% /VL=UD April 11 CD4=569 32% /VL=UD Switched to Epizcom, Reyataz and Norvir Interrupted for 2 months with only Epizcom Reyataz July 11 CD=520 28% /VL=UD Oct 11 CD=771 31% /VL=UD 30 April 12 CD=609 28% /VL=UD 20 Aug 12 CD=657 29% /VL=UD 20 Dec 12 CD=532 31% /VL=UD 20 May 13 CD=567 31% /VL=UD 20 Jan 14 CD=521 21% /VL=UD 50. Re: Reducing the HIV infection rate Reply #102 on: December 05, 2008, 02:49:11 PM. Re: Reducing the HIV infection rate Reply #103 on: December 05, 2008, 03:54:59 PM. Re: Reducing the HIV i...
http://forums.poz.com/index.php?topic=24430.msg309779
*  Effectiveness of Antiretroviral Therapy During Acute HIV Infection - Full Text View - ClinicalTrials
Primary Outcome Measures: Difference in the level of HIV RNA at viral load set point if therapy is initiated during acute HIV infection followed by terminal treatment interruption after 12 or 32 weeks of treatment compared to that under no treatment. Secondary Outcome Measures: Difference in the level of CD4 cells if therapy is initiated during acute HIV infection followed by terminal treatment interruption after 12 or 32 weeks of treatment compared to that under no treatment Difference in the level of HIV RNA and CD4 cell numbers between therapy initiated during acute HIV infection followed by terminal treatment interruption after at least 12 weeks of treatment and no therapy at 16 weeks after discontinuation of treatment Difference in the level of HIV at viral load set point and CD4 cell number at 72 weeks after study entry if therapy is initiated during acute HIV infection followed by terminal treatment interruption at 12 weeks versus at 32 weeks. Drug: Highly Active Antiretroviral Therapy HAART Participan...
https://clinicaltrials.gov/show/NCT00705926?order=31
*  WHO | HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing da
WHO. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Skip to main content. Access. Home Alt+0. Navigation Alt+1. Content Alt+2. Search. Search the WHO .int site. Submit. Advanced search. Navigation. Home. Health topics. Data. Media centre. Publications. Countries. Programmes. Governance. About WHO. Language. عربي. 中文. English. Français. Русский. Español. RSS Feed. Youtube. Twitter. Facebook. Google +. iTunes. Play Store. Bulletin of the World Health Organization. Menu. Bulletin. Past issues. Information for contributors. Editorial members. How to order. About the Bulletin. Disclaimer. . HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Joel Negin & Robert G Cumming. Objective. To quantify the number of cases and prevalence of human immunodeficiency virus HIV infection among older adults in sub-Saharan Africa. Methods. We reviewed data from Demographic and Health Surveys DHS. Although in these surveys all female r...
http://who.int/bulletin/volumes/88/11/10-076349-ab/en/
*  hivandhepatitis.com - HIV Treatment | HIV Clinical Trials
hivandhepatitis.com - HIV Treatment. hivandhepatitis.com. Facebook. Contact Us. Get in touch Contact Us. Content Past Conferences. Conference Coverage. HIV/AIDS HIV/AIDS Topics HIV Prevention. HIV Disease Progression. HIV Populations. HIV Treatment. HIV Testing Diagnosis. HIV-Related Conditions. Hepatitis B Hepatitis B Topics HBV Treatment. HBV Disease Progression. HBV Populations. HBV Prevention. HBV Testing Diagnosis. Hepatitis C. HIV/Hepatitis Coinfection HIV/HBV Coinfection. HIV/HCV Coinfection. Other Health News Other Health News Topics Influenza. XMRV, MLV Other Retroviruses. HIV/AIDS HIV/AIDS Topics HIV Treatment. HIV Topics. HIV Disease Progression. HIV/AIDS Epidemiology. HIV Populations. HIV Treatment. Approved HIV Drugs. Experimental HIV Drugs. Treatment Guidelines. HIV Prevention. Treatment as Prevention. HIV Testing Diagnosis. HIV-Related Conditions. Liver Kidney. Opportunistic Illness. Subscribe To Our Newsletter Sign up for our free weekly e-newsletter. CONFERENCE COVERAGE. 8th International AID...
http://hivandhepatitis.org/hiv-aids/hiv-aids-topics/hiv-treatment/271,278-hiv-clinical-trials-hiv-clinical-trials/3418-counting-your-chickens-reliance-on-unreliable-information-about-medical-studies
*  Clinical and Laboratory Monitoring of Pediatric HIV Infection | Pediatric ARV Guidelines | AIDSinfo
Clinical and Laboratory Monitoring of Pediatric HIV Infection. Please send your comments with the subject line Comments on Pediatric ARV Guidelines to ContactUs@aidsinfo.nih.gov by March 20, 2015. CD4 cell count/percentage and plasma HIV RNA viral load should be measured at the time of diagnosis of HIV infection and at least every 3 to 4 months thereafter for children not on combination antiretroviral therapy cART AIII. After initiation of cART or after a change in cART regimen, children should be evaluated for clinical side effects and to support treatment adherence within 1 to 2 weeks, with laboratory testing for toxicity and viral load response recommended at 2 to 4 weeks after treatment initiation AIII. 12,14 Plasma viral load 100,000 copies/mL in older children also has been associated with high risk of disease progression and mortality, particularly if CD4 percentage is 15% see Table C in Appendix C: Supplemental Information. Monitoring of Children Receiving Antiretroviral Therapy Evaluations at Initiat...
https://aidsinfo.nih.gov/guidelines/html/2/pediatric-treatment-guideline/59/laboratory-monitoring-of-pediatric-hiv-infection-before-initiation-of--therapy
*  Human immunodeficiency virus infection among tuberculosis patients in Mumbai Sawant SS, Agrawal SR,
... Shastri JS, Pawaskar M, Kadam P - J Lab Physicians. Human immunodeficiency virus infection among tuberculosis patients in Mumbai Sandhya S Sawant, Sachee R Agrawal, Jayanthi S Shastri, Medha Pawaskar, Pradeep Kadam Department of Microbiology, B.Y.L. Aim: To determine the seroprevalence of HIV infection among TB confirmed patients in a tertiary care center in Mumbai in view of the significance of HIV in TB. Keywords: Human immunodeficiency virus, seroprevalence, Tuberculosis. How to cite this article: Sawant SS, Agrawal SR, Shastri JS, Pawaskar M, Kadam P. Human immunodeficiency virus infection among tuberculosis patients in Mumbai. How to cite this URL: Sawant SS, Agrawal SR, Shastri JS, Pawaskar M, Kadam P. Human immunodeficiency virus infection among tuberculosis patients in Mumbai. Our laboratory caters laboratory services to all such patients, and tests are carried out as per the guidelines laid down by the National AIDS Control Organization NACO, India. There were more patients in the 21-40 years ag...
http://jlponline.org/article.asp?issn=0974-2727;year=2011;volume=3;issue=1;spage=12;epage=14;aulast=Sawant
*  Acute HIV Infection Observational Study - Full Text View - ClinicalTrials.gov
... Sponsor: National Institute of Allergy and Infectious Diseases NIAID Information provided by Responsible Party : National Institute of Allergy and Infectious Diseases NIAID. The purpose of this study is to collect data and body fluid samples from people with acute or established HIV infection and from HIV uninfected people. HIV Infections. Further study details as provided by National Institute of Allergy and Infectious Diseases NIAID :. 2 Established HIV-infection. One system using such strategies has already been implemented in North Carolina, and this system will be used in this study run by the Center of HIV/AIDS Vaccine Immunology CHAVI. The study will enroll HIV infected people with acute HIV infection and their sexual partners, people with established HIV infection, and HIV uninfected people. Group 1 participants will be people with acute HIV infection. Group 2 participants will be people with established HIV infection. Group 3 participants will be HIV uninfected people. Study Population Up to 130...
https://clinicaltrials.gov/show/NCT00296660?order=61
*  Phys.org - hiv transmission(... continued page 2)
Phys.org - hiv transmission ... Home hiv transmission. News tagged with hiv transmission. 1 week. 1 week. 1 week. hiv · hiv infection · aids. Adult circumcision has been proposed as a possible HIV prevention strategy for gay men, but a new study by the University of Pittsburgh Graduate School of Public Health presented at the XVIII International AIDS Conference ... Jul 22, 2010 in HIV & AIDS. The BC Centre of Excellence in HIV/AIDS BC-CfE published an important study today in the globally respected Lancet medical journal. The study strongly reinforces the view that the benefits of highly active antiretroviral ... Jul 19, 2010 in HIV & AIDS. Introduction of highly active antiretroviral treatment for HIV patients has halved new HIV diagnoses since 1996. A Canadian study being presented at the forthcoming International AIDS Society IAS conference shows that the annual number of new HIV diagnoses has more than halved since the introduction of highly active antiretroviral ... Jul 18, 2010 in HIV & AIDS. Researcher...
http://phys.org/tags/hiv transmission/sort/rank/all/page2.html
*  "MEN ON FILM: How Media Depictions of Black MSM Impact HIV Infection Rates" - CHIPTS | Center for HI
men on film how media depictions of black msm impact hiv infection rates chipts center for hiv identification prevention and treatment services home news about affiliated organizations aids research centers community advisory board contact us cores directions history mission scientific advisory board welcome people cab members researchers projects resources hiv implementation science behavioral economics hiv intervention research clinical trial of prep in l a funding opportunities links intervention manuals nih publication compliance policy briefs surveys scales youtube events archived events upcoming events eztel conference room calendar blog get involved donate employment join a study volunteering events men on film how media depictions of black msm impact hiv infection rates men on film how media depictions of black msm impact hiv infection rates loading map west hollywood city council chambers n san vicente blvd west hollywood details date time date s dec am pm location west hollywood city council chamber...
http://chipts.ucla.edu/events/men-film-media-depictions-black-msm-impact-hiv-infection-rates/
*  IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfect
... ed Children and Adolescents - Full Text View - ClinicalTrials.gov. IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents This study is enrolling participants by invitation only. Official Title: IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents. Methylphenidate Subjects will be stratified by medication, HIV status and HIV antiretroviral therapy as follows: Stratum A - 15 HIV uninfected subjects; Stratum B - 15 HIV-1 infected subjects who are taking concomitant prescribed efavirenz; Stratum C - 15 HIV-1 infected subjects who are taking a prescribed protease inhibitor PI * with concomitant ritonavir at boosting doses or lopinavir/ritonavir. Amphetamine / dextroamphetamine Subjects will be stratified by medication, HIV status and HIV antiretroviral therapy as follows: Stratum A - 15 HIV uninfected subjects; Stratum B - 15 HIV-1 infected subjects who are taking...
https://clinicaltrials.gov/show/NCT01232361?order=121
*  BMC Pediatrics | Abstract | A retrospective study of Human Immunodeficiency Virus transmission, mort
bmc pediatrics abstract a retrospective study of human immunodeficiency virus transmission mortality and loss to follow up among infants in the first months of life in a prevention of mother to child transmission programme in an urban hospital in kwazulu natal south africa biomedcentral com bmcpediatr article bottom top biomed central journals gateways search bmc pediatrics biomed central for go advanced search home articles authors reviewers about this journal my bmc pediatrics bmc pediatrics infection volume viewing options abstract full text pdf kb additional files associated material pubmed record article metrics open badges readers comments pre publication history related literature cited by google blog search other articles by authors on google scholar chetty t knight s giddy j crankshaw tl butler lm newell ml on pubmed chetty t knight s giddy j crankshaw tl butler lm newell ml related articles pages on google on google scholar on pubmed tools download references download xml order reprints post a comme...
http://biomedcentral.com/1471-2431/12/146/abstract
*  Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large c
... ross-sectional study of HIV-infected patients on antiretroviral therapy - Gianotti - 2012 - HIV Medicine - Wiley Online Library. Skip to Main Content. Log in / Register. Log In. E-Mail Address. Password. Forgotten Password. Remember Me. Register. Institutional Login. Home. Microbiology Virology. Infectious Disease. HIV Medicine. Vol 14 Issue 3. Abstract. JOURNAL TOOLS Get New Content Alerts. Get RSS feed. Save to My Profile. Get Sample Copy. Recommend to Your Librarian. JOURNAL MENU Journal Home FIND ISSUES Current Issue. All Issues FIND ARTICLES Early View. Most Accessed. Most Cited. GET ACCESS Subscribe / Renew. FOR CONTRIBUTORS OnlineOpen. Author Guidelines. Submit an Article. ABOUT THIS JOURNAL Society Information. News. Overview. Editorial Board. Permissions. Advertise. Contact. SPECIAL FEATURES Wiley's Infectious Disease Collection. Follow us on Twitter. Free Guidelines. Wiley Job Network. Jobs. Original research You have free access to this content Number of daily pills, dosing schedule, self-repor...
http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1293.2012.01046.x/abstract
*  Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: Secondary analyses of
... pooled community based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa ALPHA - ResearchGate. Article Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: Secondary analyses of pooled community based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa ALPHA. We used longitudinal data from the Analysing Longitudinal Population-based HIV/AIDS data on Africa ALPHA network to estimate the excess mortality associated with HIV during pregnancy and the post-partum period in sub-Saharan Africa. Mean prevalence of HIV infection across all person-years in the pooled data was 17 2% 95% CI 17 0-17 3, but 60 of 118 50 8% of the women of known HIV status who died during pregnancy or post partum were HIV infected. We used longitudinal data from the Analysing Longitudinal Population-based HIV/AIDS data on Africa ALPHA network to estimate the excess mortality associated with HIV during pregnancy and the post-partum per...
http://researchgate.net/publication/236918075_Effect_of_HIV_infection_on_pregnancy-related_mortality_in_sub-Saharan_Africa_Secondary_analyses_of_pooled_community_based_data_from_the_network_for_Analysing_Longitudinal_Population-based_HIVAIDS_data_on_Africa_(ALPHA)
*  HIV Tests Cost, How much Do HIV Tests Cost
... HIV Symptoms. HIV Tests Cost HIV human immunodeficiency virus leads to develop AIDS. This virus attacks on the CD4 cells that are known to be the soldier cells in human body. It replicates itself and eventually overcomes the CD4 cells and immune system succumbs to develop AIDS. There are various HIV tests available for detecting the existence of HIV in human body. However, HIV tests cost differs from test to test. Various tests and their cost are given below : Rapid HIV tests A rapid HIV test is a screening test that offers very quick results, normally in five to thirty minutes. Single Use Diagnostic System is the rapid test that is approved by FDA in USA. What is the cost of a rapid HIV test. Does the rapid HIV test cost more than the EIA. Single Use Diagnostic System SUDS test kit normally costs $6to $10. The individual kit of rapid test is more expensive than the EIA test. Hospital cost for HIV tests A screening test for HIV antibodies might cost $12 at some hospitals in Illinois hospital. Cost of Hom...
http://hivsymptomsonline.com/hiv-test-cost.html
*  Body Shape Changes Research: 2004 - TheBody.com
In The XV International AIDS Conference On TheBodyPRO.com A HAART Regimen With Lower Metabolic Effect: Nevirapine Plus Non-Thymidine Analog NRTIs July 14, 2004 In The XV International AIDS Conference , from TheBodyPRO.com Kidney Fat Could Be a Predictor of Lipodystrophy July 6, 2004 Researchers use ultrasound to gauge the likelihood a patient will develop lipodystrophy after starting HAART, or whether a treatment switch will improve existing lipodystrophy. From aidsmap.com On TheBodyPRO.com Vitamins and Exercise May Help HIV-Related Metabolic Disorders June 19, 2004 In The Advocate Vitamins, Exercise May Help Metabolic Disorders June 16, 2004 In CDC HIV/Hepatitis/STD/TB Prevention News Update , from CDC National Prevention Information Network Lipid-Lowering Drug Helps Triglyceride Levels in HIVers With Lipodystrophy June 2004 A daily dose of fenofibrate is found to lower abnormally high triglyceride levels in HIV-positive people with lipodystrophy, without causing any severe side effects. From aidsmap.com On ...
http://thebody.com/index/subtopic/lipo_res_2004.html
*  Psychological Issues in Patients With Primary HIV Infection - TheBodyPRO.com
... Get Email Updates Patients Visit TheBody.com. Print-Friendly. Wrap-Up Psychological Issues in Patients With Primary HIV Infection. From The Center for AIDS. In particular, depression is the most common psychiatric disorder among HIV-infected patients and pharmacological intervention may be warranted. Persons diagnosed with primary HIV infection PHI are faced with psychological challenges unique to their early disease stage. A PHI patient presenting with symptoms such as fevers, rash, or diarrhea may confuse these symptoms with those of AIDS. Patients with PHI should first be assured that they do not have AIDS and that PHI is an early disease stage after which many people remain healthy for 10 years or longer, even without treatment. Of equal concern, especially if the clinician decides to initiate antiretroviral therapy during PHI, is that patients understand why they will be taking potent drugs to fight HIV when most chronically infected people are advised to wait until mid- or late-stage disease before...
http://thebodypro.com/content/art16815.html
*  Connecting Lower HIV Infection Rates with Changes in Sexual Behaviour in Thailand - Data collection
connecting lower hiv infection rates with changes in sexual behaviour in thailand data collection and comparison unaids p home help preferences search titles subjects organizations expand text expand contents detach no highlighting connecting lower hiv infection rates with changes in sexual behaviour in thailand data collection and comparison unaids p introduction introduction hiv in thailand the early days epidemiological information behavioural information linking epidemiological patterns with behaviour keeping track of a dynamic epidemic conclusion...
http://nzdl.org/gsdlmod?e=d-00000-00---off-0unaids--00-0----0-10-0---0---0direct-10---4-------0-1l--11-en-50---20-preferences---00-0-1-00-0--4----0-0-11-10-0utfZz-8-00&a=d&c=unaids&cl=CL1.1&d=HASH0196a4d22e0be33e37d419ae
*  NEUROCOGNITIVE PROBLEM RATE LOW WITH EARLY HIV DIAGNOSIS IN US
... POZ Community Forums. NEUROCOGNITIVE PROBLEM RATE LOW WITH EARLY HIV DIAGNOSIS IN US. Meds, Mind, Body Benefits Questions About Treatment Side Effects Insurance, Benefits Programs HIV Mental Health HIV Lipodystrophy Metabolic Problems Nutrition HIV Research News Studies. Author Topic: NEUROCOGNITIVE PROBLEM RATE LOW WITH EARLY HIV DIAGNOSIS IN US Read 857 times. NEUROCOGNITIVE PROBLEM RATE LOW WITH EARLY HIV DIAGNOSIS IN US on: March 03, 2013, 06:44:38 AM. NEUROCOGNITIVE PROBLEM RATE LOW WITH EARLY HIV DIAGNOSIS IN US http://www.iasociety.org/Default.aspx?pageId=5 elementId=15025 ic=700100 Author: Mark Mascolini 22 February 2013 US military beneficiaries diagnosed with HIV and cared for early in the course of infection had a neurocognitive impairment rate similar to that of a matched group of military beneficiaries without HIV. The findings suggest that early HIV diagnosis and management may forestall development of neurocognitive problems in HIV-positive people. Because there is little information on ho...
http://forums.poz.com/index.php?topic=47637.0
*  .. New Study of HIV Hot Spots
← Intratumor Heterogeneity aka, Things Have Many Parts Avastin for Lung Cancer →. New Study of HIV Hot Spots By Jessica Wapner Posted: March 14, 2012. HIV infection rates of black women in certain parts of the United States is five times higher than the overall rate of infection among black women, according to a newly published study by the HIV Prevention Trials Network HPTN. The study, HPTN 064, looked at HIV rates in six geographic “hot spots”; that is, regions of the U.S. known to have elevated rates of HIV and poverty. HPTN 064 also called “The Women’s HIV SeroIncidence Study, which somehow qualifies for the questionable acronym “ISIS” enrolled women ages 18 to 44 without a prior positive HIV test. Among the 2,099 women enrolled in the study, 88% of whom were black, the HIV incidence was 0.24%. As a measure of comparison, here is a char t showing HIV/AIDS rates in sub-Saharan Africa, though note that the rates show HIV/AIDS, not non-AIDS HIV Enrollees in HPTN 064 were asked about their mental health, sexu...
http://blogs.plos.org/workinprogress/2012/03/14/new-study-of-hiv-hot-spots/
*  Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults - Full
Safety of and Immune System Response to an HIV Vaccine EP HIV-1090 in HIV Uninfected Adults - Full Text View - ClinicalTrials.gov. Safety of and Immune System Response to an HIV Vaccine EP HIV-1090 in HIV Uninfected Adults This study has been completed. Sponsor: National Institute of Allergy and Infectious Diseases NIAID Information provided by Responsible Party : National Institute of Allergy and Infectious Diseases NIAID. The purpose of this study is to test the safety of an HIV DNA vaccine EP HIV-1090 and to test whether or not the vaccine can stimulate immune system responses in HIV uninfected people. Further study details as provided by National Institute of Allergy and Infectious Diseases NIAID :. Criteria Inclusion Criteria HIV negative Positive for one or more of the following HLA supertypes: -A2, -A3, or -B7 Willing to receive HIV test results Good general health Acceptable methods of contraception for females of reproductive potential Hepatitis B surface antigen negative Anti-hepatitis C virus antib...
https://clinicaltrials.gov/ct2/show/study/NCT00054860?view=results
*  Gender Difference in Mucosal Integrity Impacts Response to HAART in HIV Infection
... 19th Conference on Retroviruses and Opportunistic Infections Seattle, WA March 5 - 8, 2012. Gender Difference in Mucosal Integrity Impacts Response to HAART in HIV Infection. Women have higher levels of T cell activation at all stages of HIV infection and during HAART. These preliminary data suggest that increased microbial translocation may explain why women have sustained CD4+T-cell activation despite effective viral suppression. The increased microbial translocation could be the result of decreased or ineffective tight junction formation or increased disruption of the tight junctions due to a combination of infection and hormonal factors. HIV infection results in loss of CD4+ T-cells in Gut- Associated Lymphoid Tissue GALT and in compromised gut epithelial integrity. HIV disease progression correlates with immune activation, which is higher in women compared to men. HIV positive women on HAART have higher levels of T-cell activation than HIV positive men on HAART. We hypothesize that the compromised m...
http://natap.org/2012/CROI/croi_118.htm
*  Ziagen User Reviews for HIV Infection at Drugs.com
... Search:. All Consumer Professional Pill ID Interactions News FDA Alerts Approvals Pipeline Clinical Trials Care Notes Encyclopedia Dictionary Natural Products. Advanced Search. Sign In. Sign In. Sign In. Drugs A-Z. Drugs by Condition. Drugs by Class. Generic Drugs. OTC Drugs. Natural Products. Pregnancy Warnings. Advanced Search. News. Apps. Drugs A to Z. Ziagen. User Reviews. User Reviews for Ziagen The following information is NOT intended to endorse drugs or recommend therapy. Learn more about Ziagen. Reviews for Ziagen to treat HIV Infection No reviews have yet been submitted. Learn more about HIV Infection Micromedex Care Notes: Aids. Aids, Ambulatory Care. Hiv Infection. Sexually Transmitted Diseases. Sexually Transmitted Diseases In Adolescents. Sexually Transmitted Diseases In Adolescents, Ambulatory Care. Sexually Transmitted Diseases, Ambulatory Care Symptoms and treatment for: HIV/AIDS Drugs.com Health Center: AIDS / HIV. Treating AIDS & HIV. AIDS / HIV Symptoms and Complications. 9 Facts Abou...
http://drugs.com/comments/abacavir/ziagen-for-hiv-infection.html
*  Bureau of HIV, STD, and Hepatitis - HIV/AIDS Program
... Home. A-Z Index. What We Do. News. Calendar. Employment. Definitions. Contact Us. Take Our Survey. County Public Health Contacts. HIV / AIDS Program Home. HIV Community Planning Group. Prevention Program. HIV/AIDS: Resources & Links. Care & Support Services. Data & Statistics. HIV/AIDS Program. STD Program. Hepatitis Program HIV Prevention Program The HIV/AIDS Program receives HIV prevention funds from the Centers for Disease Control and Prevention CDC to provide for HIV counseling and testing, partner counseling and referral services, health education/risk reduction activities and health communication/public information activities. These activities are targeted to high-risk individuals as defined in Iowa’s HIV Prevention Comprehensive Plan. The funding is also awarded to support HIV prevention community planning, technical assistance and capacity building activities. Online Resource Directory for Gay/Bi/Trans Men in Iowa Counseling, Testing, and Referral Sites. HIV Services Directory. Perinatal Guidel...
http://idph.state.ia.us/HivStdHep/HIV-AIDS.aspx?prog=Hiv&pg=HivPrev
*  Effective HIV care benefited all HIV patients, regardless of demographics and behavioral risk
... HIV/AIDS What Is AIDS. AIDS/HIV Symptoms Symptoms and phases AIDS HIV Prevention AIDS HIV Detection Transmission of HIV Sexual acts Transmission Acute HIV infection What causes AIDS HIV / AIDS FAQ Early hiv symptoms HIV and AIDS Symptoms Myths about HIV transmission Basic management and monitoring I'm HIV positive AIDS/HIV Detection & Treatment Immunotherapy for HIV Infection HIV and Hepatitis C in prisons. Introduction to HIV Immunology Related to AIDS The impact of HIV and AIDS Biology of Human Immunodeficiency Viruses Epidemiology of HIV infection Prevention of HIV infection Neurologic Complications of HIV-1 Infection Pulmonary Manifestations of HIV Infection. Gastrointestinal Manifestations of AIDS Cutaneous Signs of AIDS Ophthalmologic Manifestations of AIDS Hematology/Oncology in AIDS Renal, Cardiac, Endocrine, and Rheumatologic Manifestations of HIV Infection Treatment of HIV infection and AIDS Management and Counseling for persons with HIV infection. Sexually Transmitted Infections Bacterial Infe...
http://health.am/aids/more/effective-hiv-care-benefited-all-hiv-patients/
*  University of Pennsylvania HIV Prevention Research Division | The Fix
University of Pennsylvania HIV Prevention Research Division. Skip to main content Search form Search Search. NEWS FEATURES BLOGS LIVING SOBER ASK AN EXPERT PRO VOICES QUIZZES ABOUT US. Trending Rehab Reviews Treatment Centers Resources. Will My Insurance Pay for Rehab. Rehab Directory Cash Pay Treatment for VIPS and Execs How to Choose the Best Rehab Interventionists Sober Livings Pain Management Mental Health Buprenorphine doctors Rehab Detox Insurance. NEWS FEATURES BLOGS LIVING SOBER ASK AN EXPERT PRO VOICES QUIZZES ABOUT US. This is an advertisement and the insurance benefit check is a service performed by one of The Fix’s advertising sponsors. This is an advertisement and the insurance benefit check is a service performed by one of The Fix’s advertising sponsors. This is an advertisement and the insurance benefit check is a service performed by one of The Fix’s advertising sponsors. Trending Rehab Reviews Treatment Centers Resources. Will My Insurance Pay for Rehab. Rehab Directory Cash Pay Treatment for...
https://thefix.com/tags/university-pennsylvania-hiv-prevention-research-division
*  AIDSinfo At-a-Glance | Issue No. 9 | March 02, 2012
FDA Issues Safety Announcement About Interactions Between Certain HIV or Hepatitis C Drugs and Cholesterol-Lowering Statin Drugs The U.S. Food and Drug Administration FDA is issuing updated recommendations concerning drug-drug interactions between drugs for human immunodeficiency virus HIV or hepatitis C virus HCV known as protease inhibitors and certain cholesterol-lowering drugs known as statins. The labels for both the HIV protease inhibitors and the affected statins have been updated to contain consistent information about the drug-drug interactions. Study Examines Effect of HIV Infection, Immunodeficiency, and Antiretroviral Therapy on the Risk of Hepatic Dysfunction Limited data exists regarding the effect of chronic HIV infection on the liver. We sought to characterize the hepatic risks of HIV infection, immunodeficiency and cumulative use of antiretroviral therapy ART. Adult HIV-infected and 10:1 age- and sex-matched HIV-uninfected individuals were followed for incident hepatic dysfunction or hepatic ...
https://aidsinfo.nih.gov/e-news/archive/2012/3/2
*  Phys.org - hiv transmission(... continued page 3)
Phys.org - hiv transmission ... Home hiv transmission. News tagged with hiv transmission. 1 week. 1 week. 1 week. hiv · hiv infection · aids. Some HPV infection may be linked to increased risk of HIV acquisition in women. PhysOrg.com -- UCSF researchers have found a novel association between human papillomavirus HPV infection and increased HIV acquisition in women. Expansion of HIV screening cost-effective in reducing spread of AIDS, Stanford study shows. program of HIV screening and treatment could prevent as many as 212,000 new infections over the next 20 years and prove to be very cost-effective, according to a new study by Stanford University School of ... Study examines risk of heterosexual HIV transmission in China. 6-month drug regimen cuts HIV risk for breastfeeding infants. Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug ... Mo...
http://phys.org/tags/hiv transmission/sort/popular/all/page3.html
*  Study Suggests Immune Systems of Untreated HIV-Infected Individuals May Deteriorate Faster Than Prev
... iously Thought - TheBodyPRO.com. Press Release Study Suggests Immune Systems of Untreated HIV-Infected Individuals May Deteriorate Faster Than Previously Thought. National Institute of Allergy and Infectious Diseases. July 29, 2009 The immune systems of untreated HIV-infected individuals appear to deteriorate faster than previously thought, according to preliminary results of a small clinical trial. Known as the SETPOINT study, or A5217, the trial was designed to compare the point at which the amount of HIV in the blood levels off in two groups of people with recent HIV infection: those who receive a 36-week course of antiretroviral therapy ART , and those who receive no therapy until they meet immunologic, virologic or clinical criteria for starting ART. Since it is commonly thought that people with untreated HIV infection lose approximately 60 CD4+ T cells/mm 3 per year, and since U.S. Advertisement The SETPOINT study has been conducted by the Acute Infection and Early Disease Research Program and the A...
http://thebodypro.com/content/art53110.html?nxtprv
*  Rural counties experience funding and stigma problems in HIV prevention services | AHRQ Archive
Rural counties experience funding and stigma problems in HIV prevention services. AHRQ Archive. www.ahrq.gov AHRQ Home—Live Site. Please go to www.ahrq.gov for current information. HIV/AIDS Research Rural counties experience funding and stigma problems in HIV prevention services. Healthcare 411. Rural counties experience funding and stigma problems in HIV prevention services Research Activities, January 2011, No. 365 As local HIV prevention agencies fight growing rates of HIV infection, they have fewer and fewer resources, making it difficult for them to maintain existing programs and services, as well as launch new programs. Over 400 informants were asked about performance of county health services, HIV prevention activities, community attitudes, and community cooperation and collaboration. Agency representatives at 169 agencies were asked to evaluate how well their agency performed on HIV prevention-related services, such as accessibility and cost of services. The researchers found that informants in rural ...
http://archive.ahrq.gov/news/newsletters/research-activities/jan11/0111RA21.html
*  .. HIV/AIDS Treatment as Prevention strategy working in B.C. Montaner calls for national implementa
Email. HIV/AIDS Treatment as Prevention strategy working in B.C. Montaner calls for national implementation. Media Release. November 27, 2012. A new study from the BC Centre for Excellence in HIV/AIDS BC-CfE shows highly active antiretroviral therapy HAART reduces new HIV diagnoses, deaths and HIV prevalence, suggesting that the made-in-Canada Treatment as Prevention strategy should be implemented across the country. The study, published today in the online journal PLOS One, investigated patterns of new HIV diagnoses, HIV-related mortality and HAART use in Canada from 1995 to 2008. Analysis showed that for each 10 per cent increment in HAART coverage, the rate of new HIV diagnoses decreased by eight per cent in B.C., Ontario and Quebec — three provinces with the largest epidemics. In B.C., the Treatment as Prevention strategy has led to the widespread expansion of HAART coverage. The total number of new HIV diagnoses in the province dropped during the period of the study from 682 in 1995 to 348 in 2008, and...
http://news.ubc.ca/2012/11/27/ubc-study-reinforces-need-for-national-implementation-of-treatment-as-prevention-strategy-to-save-lives-fight-hivaids/
*  HOME | hivandhepatitis.com
HIV Disease Progression. HIV Testing Diagnosis. HBV Disease Progression. HBV Prevention. HBV Testing Diagnosis. HIV/Hepatitis Coinfection HIV/HBV Coinfection. HIV/HCV Coinfection. HIVandHepatitis.com coverage of the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention IAS 2015 , July 19-22, in Vancouver, Canada. Coverage of the 2015 EASL International Liver Congress. HIVandHepatitis.com coverage of the 50th European Association for the Study of the Liver International Liver Congress EASL 2015 in Vienna, April 22-26, 2015. Conference highlights include interferon-free hepatitis C treatment for people with advanced disease, experimental HCV antivirals, hepatitis B and delta, and management of liver disease complications. Coverage of the 2015 Conference on Retroviruses and Opportunistic Infections. HIVandHepatitis.com coverage of the 2015 Conference on Retroviruses and Opportunistic infections CROI 2015 , February 23-26, 2015, in Seattle. Conference highlights include PrEP and HIV ...
http://hivandhepatitis.com/recent/2008/101408_c.html
*  Burlington NC Infectious Disease Specialist Doctors - Tularemia: Learn About Symptoms and Treatment
Bell University Of North Carolina Infectious Diseases Clinic 101 Manning Dr Chapel Hill, NC 27514 919 966-2536 1 office location s. Sparling University Of North Carolina Infectious Diseases Clinic 101 Manning Dr Chapel Hill, NC 27514 919 966-2536 1 office location s. Weber University Of North Carolina Infectious Diseases Clinic 101 Manning Dr Chapel Hill, NC 27514 919 966-2536 2 office location s. Gay University Of North Carolina Infectious Diseases Clinic 101 Manning Dr Chapel Hill, NC 27514 919 966-2536 1 office location s. Patterson University Of North Carolina Infectious Diseases Clinic 101 Manning Dr Chapel Hill, NC 27514 919 966-2536 1 office location s. Barroso Wake Forest Baptist Health Outpatient Infectious Disease Clinic Medical Center Blvd Winston-Salem, NC 27157 336 716-4395 1 office location s. Peacock Wake Forest Baptist Health Outpatient Infectious Disease Clinic Medical Center Blvd Winston-Salem, NC 27157 336 716-4395 1 office location s. Schafer Wake Forest Baptist Health Outpatient Infectiou...
http://medicinenet.com/tularemia/burlington-nc_city.htm
*  Prevention of Parent to Child Transmission - Overview of HIV/AIDS in India
... HIV/AIDS What Is AIDS. AIDS/HIV Symptoms Symptoms and phases AIDS HIV Prevention AIDS HIV Detection Transmission of HIV Sexual acts Transmission Acute HIV infection What causes AIDS HIV / AIDS FAQ Early hiv symptoms HIV and AIDS Symptoms Myths about HIV transmission Basic management and monitoring I'm HIV positive AIDS/HIV Detection & Treatment Immunotherapy for HIV Infection HIV and Hepatitis C in prisons. Introduction to HIV Immunology Related to AIDS The impact of HIV and AIDS Biology of Human Immunodeficiency Viruses Epidemiology of HIV infection Prevention of HIV infection Neurologic Complications of HIV-1 Infection Pulmonary Manifestations of HIV Infection. Gastrointestinal Manifestations of AIDS Cutaneous Signs of AIDS Ophthalmologic Manifestations of AIDS Hematology/Oncology in AIDS Renal, Cardiac, Endocrine, and Rheumatologic Manifestations of HIV Infection Treatment of HIV infection and AIDS Management and Counseling for persons with HIV infection. Sexually Transmitted Infections Bacterial Infe...
http://health.am/aids/more/prevention-of-parent-to-child-transmission/
*  National HIV/AIDS Clinicians' Consultation Center
... 'National HIV/AIDS Clinicians' Consultation Center NCCC ' is a free expert clinical consultation service for healthcare providers seeking consultation on HIV / AIDS and management of potential exposures to HIV, hepatitis, and other blood-borne pathogens. http://www.cdc.gov/hiv/topics/basic/index.htm#history Healthcare professionals who frequently use the Warmline, PEPline, and Perinatal HIV Hotline include physicians, nurses, physician assistants, pharmacists, dentists, and other allied health professionals seeking expert consultation. 'The Warmline' 'National HIV Telephone Consultation Service' 1-800-933-3413 is a clinical consultation service that provides free advice from HIV expert clinicians on HIV/AIDS management and prevention of transmission. 'The PEPline' 'National Clinicians’ Post-Exposure Prophylaxis Hotline' 1-888-448-4911 provides around-the-clock expert guidance on managing healthcare worker exposures to HIV and hepatitis B and C through needlestick injury, splashes, etc. 'The Perinatal HIV...
https://en.wikipedia.org/wiki/National_HIV/AIDS_Clinicians'_Consultation_Center
*  Medical Xpress - hiv infection rates
... Home hiv infection rates. News tagged with hiv infection rates. sort by:. Date. 6 hours. 12 hours. 1 day. 3 days. all. Rank. Last day. 1 week. 1 month. all. LiveRank. Last day. 1 week. 1 month. all. Popular. Last day. 1 week. 1 month. all. Sorry, no news articles match your request. Your search criteria may be too narrow. Subscribe to rss feed. Topics. Addiction. Alzheimer's disease & dementia. Arthritis & Rheumatism. Attention deficit disorders. Autism spectrum disorders. Cancer. Cardiology. Dentistry. Diabetes. Diseases, Conditions, Syndromes. Genetics. Health. HIV & AIDS. Immunology. Inflammatory disorders. Medical research. Medications. Neuroscience. Obstetrics & gynaecology. Ophthalmology. Other. Overweight and Obesity. Parkinson's & Movement disorders. Pediatrics. Psychology & Psychiatry. Sleep apnea. Surgery. Conditions. Asthma. Breast cancer. Cardiovascular disease. Chronic obstructive pulmonary disease. Colon cancer. Coronary artery disease. Dementia. Depression. Heart attack. Heart disease. Hig...
http://medicalxpress.com/tags/hiv infection rates/sort/liverank/1d/
*  Publications: Moore, Corey - Murdoch Research Repository
... Publications: Moore, Corey. Stats for Moore, Corey. , Moore, C. , Mallal, S. , St John, M.A. , Moore, C. , Mallal, S. , Allen, T.M. , Walker, B.D. and Brander, C. , Nolan, D. , James, I. , Gaudieri, S. , Moore, C. and Mallal, S. Journal of Virology, 80 18. Gaudieri, S. , Lucas, M. , Moore, C. 2005 Adaptation of Hepatitis C virus to HLA-restricted responses in an Australian host population. 2005 Adaptation of Hepatitis C virus to HLA-restricted responses in an Australian host population. 2004 Adaptation of Hepatitis C virus to HLA-restricted responses in HLA diverse populations. 2004 Adaptation of hepatitis C virus to HLA-restricted responses in HLA diverse populations. 2003 HIV adaptation to HLA-restricted immune responses - implications for vaccine design and evaluation. In: 10th Conference on Retroviruses and Opportunistic Infections, 10 - 14 February 2003, Boston, U.S.A. 2002 Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level. Moore, Corey Benjamin 2002 Evidence of H...
http://researchrepository.murdoch.edu.au/view/author/Moore, Corey.date.html
*  Benefits and Risks of Early Antiretroviral Therapy for HIV | Health Encyclopedia | Keene | Dartmouth
Benefits and Risks of Early Antiretroviral Therapy for HIV. Health Encyclopedia. Keene. Dartmouth-Hitchcock. Dartmouth-Hitchcock. Contact Us. Site Map. Cheshire Medical Center/Dartmouth-Hitchcock Keene. Patients & Visitors. Clinical Care. Health & Wellness. Healthy Monadnock. Careers. Health Encyclopedia. Health & Wellness. Health Encyclopedia. Benefits and Risks of Early Antiretroviral Therapy for HIV. Medical experts recommend that people begin treatment for HIV as soon as they know that they are infected. 2 Treatment is especially important for pregnant women, people who have other infections such as tuberculosis or hepatitis, and people who have symptoms of AIDS. Benefits and risks of antiretroviral therapy for HIV. Early therapy : Treatment with antiretroviral medicines as soon as HIV is diagnosed. Delayed therapy : Treatment with antiretroviral medicines some time after HIV is diagnosed. Benefits. Even with early therapy, the risk of HIV transmission still exists. Risks. Possible risks of starting antir...
http://cheshire-med.com/health_wellness/health_encyclopedia/aa5845
*  Thomas R Fleming
Publications Current issues in non-inferiority trials Thomas R Fleming Department of Biostatistics, University of Washington, Seattle, WA 98195, USA Stat Med 27:317-32. 2005 Some design issues in trials of microbicides for the prevention of HIV infection Thomas R Fleming Department of Biostatistics, University of Washington, Seattle, Washington 98195, USA J Infect Dis 190:666-74. Research Grants HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUP Thomas Fleming; Fiscal Year: 2005 STATISTICAL ISSUES IN AIDS RESEARCH Thomas Fleming; Fiscal Year: 2007 Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network Thomas Fleming; Fiscal Year: 2007 CLINICAL RESEARCH ON AIDS TRAINING GRANT Thomas Fleming; Fiscal Year: 2007. Some design issues in trials of microbicides for the prevention of HIV infection Thomas R Fleming Department of Biostatistics, University of Washington, Seattle, Washington 98195, USA J Infect Dis 190:666-74. Some essential considerations in the design and conduct of non-inferiority ...
http://labome.org/expert/usa/university/fleming/thomas-r-fleming-226403.html
*  hivandhepatitis.com - Gilead Requests FDA Approval of Truvada for HIV Prevention | HIV Prevention
hivandhepatitis.com - Gilead Requests FDA Approval of Truvada for HIV Prevention. HIV/AIDS HIV/AIDS Topics HIV Prevention. HIV Disease Progression. Hepatitis B Hepatitis B Topics HBV Treatment. HBV Disease Progression. HBV Prevention. HBV Testing Diagnosis. HIV/AIDS HIV/AIDS Topics. HIV Prevention Gilead Requests FDA Approval of Truvada for HIV Prevention. Gilead Requests FDA Approval of Truvada for HIV Prevention Details Category: HIV Prevention. Gilead Sciences announced this week that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration FDA requesting approval of a new indication for Truvada, its tenofovir/emtricitabine combination pill, for HIV pre-exposure prophylaxis PrEP. As described this summer at the International AIDS Society conference in Rome, the iPrEx study of gay men and the Partners PrEP and TDF2 trials of heterosexual men and women showed that once-daily Truvada PrEP dramatically reduced the risk of infection. However, the Fem-PrEP study of daily teno...
http://hivandhepatitis.net/hiv-aids/hiv-aids-topics/hiv-prevention/3394-gilead-requests-fda-approval-of-truvada-for-hiv-prevention
*  World AIDS Day -- December 1, 1996
... Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation in the subject line of e-mail. World AIDS Day -- December 1, 1996 One World, One Hope is the theme designated by the Joint United Nations Programme on HIV/AIDS UNAIDS for this year's World AIDS Day, December 1, 1996. Worldwide, 190 countries observe World AIDS Day to focus attention on the human immunodeficiency virus HIV /acquired immunodeficiency syndrome AIDS pandemic, which has resulted in an estimated 27.9 million HIV infections and 5.8 million deaths, including 1.3 million deaths in children 1,2. In the United States, activities for World AIDS Day are coordinated by the American Association for World Health in collaboration with UNAIDS, the Pan American Heath Organization, and the U.S. Department of Health and Human Services. Additional information about HIV infection, AIDS, and World AIDS Day is available from the CDC National A...
http://cdc.gov/mmwr/preview/mmwrhtml/00044513.htm
*  Probable Acquisition of Multi-Drug-Resistant HIV in Man With Subsequent Rapid HIV Disease Progressio
The Body Covers: The 12th Conference on Retroviruses and Opportunistic Infections Probable Acquisition of Multi-Drug-Resistant HIV in Man With Subsequent Rapid HIV Disease Progression: Reality and Reaction Coverage provided by David A. Beyond the hype, this case report raises serious questions regarding the relationship between transmission of drug-resistant virus and rapid HIV disease progression, as well as the adequacy of HIV prevention efforts. During this special session, data from 2 large cohort studies of individuals at risk for HIV infection, the Multicenter AIDS Cohort Study MACS and the Women's Interagency HIV Study WIHS, and a cohort of recently infected military personnel were reviewed with respect to the variability of the pace of HIV progression following acquisition of the virus. Abstract: Introductory Remarks and Summary of Case Report of Recent Infection by a Multi-Drug Resistant, Dual-Tropic HIV-1 in Association with Rapid Progression to AIDS Authored by: D Ho Affiliations: Aaron Diamond AID...
http://thebody.com/content/art14848.html?nxtprv
*  Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for ea
... rly infant diagnosis in high HIV prevalence settings. University of California, San Francisco. Comprehensive, up-to-date information on HIV/AIDS treatment, prevention, and policy from the University of California San Francisco. Universal HIV Testing. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. In Context The World Health Organization WHO recommends early initiation of antiretroviral therapy ART in HIV-infected infants. 4 Objective To determine the acceptability and feasibility of HIV testing of infants presenting for immunization Setting Three primary care clinics in KwaZulu Natal, South Africa Study Design Non-randomized, single-arm intervention Participants Infants attending any of the first three immunizations given at 6, 10, and 14 weeks of a...
http://hivinsite.ucsf.edu/InSite?page=jl-58-04
*  hivandhepatitis.com - AIDS 2012: Switching from Protease Inhibitor to Complera Maintains Viral Suppr
... ession, Lowers Lipids. HIV/AIDS HIV/AIDS Topics HIV Prevention. HIV Disease Progression. Hepatitis B Hepatitis B Topics HBV Treatment. HBV Disease Progression. HBV Testing Diagnosis. HIV/Hepatitis Coinfection HIV/HBV Coinfection. Approved HIV Drugs AIDS 2012: Switching from Protease Inhibitor to Complera Maintains Viral Suppression, Lowers Lipids. AIDS 2012: Switching from Protease Inhibitor to Complera Maintains Viral Suppression, Lowers Lipids Details Category: Approved HIV Drugs. People who switched to the all-in-one Complera rilpivirine/tenofovir/emtricitabine combination pill from a boosted protease inhibitor continued to have undetectable viral load and on average had improved lipid profiles associated with lower cardiovascular risk, according to study findings presented at the XIX International AIDS Conference AIDS 2012 last week in Washington, DC. Results Switching to Complera was found to be non-inferior to staying on a ritonavir-boosted protease inhibitor regimen. 93.7% of participants who switc...
http://hivandhepatitis.com/hiv-treatment/approved-hiv-drugs/3713-aids-2012-switching-from-protease-inhibitor-to-complera-maintains-viral-suppression-lowers-lipids
*  Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth - Full Text View - ClinicalT
... rials.gov. Skip to Main Content. A service of the U.S. National Institutes of Health Example: "Heart attack" AND "Los Angeles" Search for studies:. Advanced Search. Help. Studies by Topic. Glossary. Find Studies. Basic Search. Advanced Search. See Studies by Topic. See Studies on Map. How to Search. How to Use Search Results. How to Find Results of Studies. How to Read a Study Record. About Clinical Studies. Learn About Clinical Studies. Other Sites About Clinical Studies. Glossary of Common Site Terms. Submit Studies. Why Should I Register and Submit Results. FDAAA 801 Requirements. How to Apply for an Account. How to Register Your Study. How to Edit Your Study Record. How to Submit Your Results. Frequently Asked Questions. Support Materials. Training Materials. Resources. Selected Publications. Clinical Alerts and Advisories. RSS Feeds. Trends, Charts, and Maps. Downloading Content for Analysis. About This Site. ClinicalTrials.gov Background. About the Results Database. History, Policies, and Laws. Medi...
https://clinicaltrials.gov/ct2/show/study/NCT00102960?view=record
*  Special Medical Reports: Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infec
... ted with HIV - American Family Physician. Advertisement. Previous article Next article. Jul 1, 1998 Issue. Special Medical Reports Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV. FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access. FREE PREVIEW. Purchase online access to read the full version of this article. VERNA ROSE Am Fam Physician. 1998 Jul 1;58 1 :261-263. The Public Health Service has updated the 1994 guidelines for the use of zidovudine Retrovir to reduce the risk for perinatal transmission of human immunodeficiency virus HIV. The new report is intended to help health care professionals educate pregnant women with HIV infection about the use of zidovudine and other antiretroviral drugs during pregnancy. The report was published in the January 30, 1998, issue of Morbidity and Mortality Weekly Report recommendations and reports series MMWR Morb Mortal Wkly Rep 1998; :1–30. The guidelines conta...
http://aafp.org/afp/1998/0701/p261.html
*  Initiating Antiretroviral Therapy in Treatment-Naive Patients | Adult and Adolescent ARV Guidelines
Search HIV/AIDS Drugs. Antiretroviral therapy ART is recommended for all HIV-infected individuals to reduce the risk of disease progression. Benefits of Antiretroviral Therapy Reduction in Mortality and/or AIDS-Related Morbidity According to Pretreatment CD4 Cell Count Patients with a History of an AIDS-Defining Illness or CD4 Count 350 cells/mm3 HIV-infected patients with CD4 counts 200 cells/mm 3 are at higher risk of opportunistic diseases, non-AIDS morbidity, and death than HIV-infected patients with higher CD4 counts. 16 The study estimated that delaying initiation of ART until CD4 count fell to 350 cells/mm 3 was associated with a greater risk of AIDS-defining illness or death than initiating ART with CD4 count between 350 cells/mm 3 and 500 cells/mm 3 HR: 1.38; 95% CI, 1.23 1.56. 18 In contrast, in an analysis of the ART-CC cohort, 13 the rate of progression to AIDS/death associated with deferral of therapy until CD4 counts fell to the 351 to 450 cells/mm 3 range was similar to the rate with initiation...
https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/10/initiating-antiretroviral-therapy-in-treatment-naive-patients
*  Re: HIV infection from dried blood? - TheBody.com's Bulletin Boards
Re: HIV infection from dried blood. - TheBody.com's Bulletin Boards. HIV Life >> Living With HIV. Re: HIV infection from dried blood. If pimple is not considered an open sore or lesion, can I take this as a true fact that even when blood containing active HIV virus contacted with this unbroken pimple, I would not be infected by HIV either. HIV infection from dried blood. Re: HIV infection from dried blood. Re: HIV infection from dried blood. Re: HIV infection from dried blood. another question on toilet panic05 06/21/05 11:25 PM. Re: another question on toilet Anonymous 06/25/05 04:15 PM. Re: another question on toilet panic05 06/25/05 07:56 PM. Re: another question on toilet debtex 06/22/05 12:28 AM. Re: another question on toilet Anonymous 06/23/05 11:24 PM. Re: another question on toilet searching 06/23/05 11:43 PM. Re: HIV infection from dried blood. Re: HIV infection from dried blood. Re: HIV infection from dried blood. Re: HIV infection from dried blood. What's New at TheBody.com. Permissions You cannot...
http://thebody.com/cgi-bin/bbs/showthreaded.php?Cat=&Board=living&Number=156324
*  A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to
... Treatment - Tabular View - ClinicalTrials.gov. A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment This study has been completed. Sponsor: University of Chicago Collaborator: Abbott Information provided by Responsible Party : David Pitrak, University of Chicago. Current Primary Outcome Measures ICMJE submitted: August 23, 2013. Current Secondary Outcome Measures ICMJE submitted: August 23, 2013. Rates of ex Vivo T Cell Apoptosis: CD4+ Memory Cell Population Ex vivo T cell apoptosis can be assessed many different ways. Rates of ex Vivo T Cell Apoptosis: CD4+ na ve Cell Population Ex vivo T cell apoptosis can be assessed many different ways. 1 Rates of ex vivo T cell apoptosis, CD4+, CD8+, both memory and na ve cell populations, 2. Current Other Outcome Measures ICMJE. A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment. Randomized Trial of a Switch to a Kaletra + Current Dual Nucleoside Reve...
https://clinicaltrials.gov/ct2/show/record/NCT00145795
*  President Obama’s mixed record on HIV/AIDS | New Pittsburgh Courier
President Obama’s mixed record on HIV/AIDS. New Pittsburgh Courier. Opinion President Obama’s mixed record on HIV/AIDS. President Obama’s mixed record on HIV/AIDS. NNPA VIENNA—Unlike any president before him, President Barack Obama has announced a national HIV/AIDS strategy, something AIDS activists had been demanding for more than a decade. president—George W. The centerpiece of the campaign is a composite photo—one half of the face of Bush merged with half of Obama’s face—with the inscription: “Who’s Better on AIDS?”. Phill Wilson, president and CEO of the Black AIDS Institute, the only African-American think tank on HIV/AIDS, believes Obama is far better than Bush on policy issues, including fulfilling his campaign pledge to create an HIV/AIDS national strategy. He said the president will be ultimately judged on whether he and other leaders reduce the HIV infection rates, especially among African-Americans. Although Blacks are only 12.8 percent of the U.S., each year African-Americans represent almost half...
http://newpittsburghcourieronline.com/2010/07/21/president-obamas-mixed-record-on-hivaids/
*  "Functional Cure" of HIV Claimed for Baby Treated 30 Hours After Birth
... Conference Reports for NATAP. 20th Conference on Retroviruses and Opportunistic Infections Atlanta, GA March 3 - 6, 2013. Back  . "Functional Cure" of HIV Claimed for Baby Treated 30 Hours After Birth. . 20th Conference on Retroviruses and Opportunistic Infections, March 3-6, 2013, Atlanta Mark Mascolini An HIV-infected US infant treated from 31 hour after birth had no detectable viral load, no detectable HIV DNA in blood cells, and no HIV-specific antibodies at 26 months of age on standard tests, even though antiretroviral therapy ART stopped at age 18 months. Deborah Persaud Johns Hopkins University and colleagues believe their findings confirm "a state of functional HIV cure." Speedy treatment after birth appeared to work like postexposure prophylaxis PEP, stopping HIV from getting a foothold in this baby's body and establishing a latent viral reservoir. Evidence that the baby was infected persisted, however, in vanishingly small levels of HIV RNA and HIV DNA detectable in blood and cells. But the...
http://natap.org/2013/CROI/croi_08.htm
*  Two immune proteins found to control HIV infection...
... POZ 100. ABOUT HIV/AIDS. What is HIV/AIDS. POZ Community Forums. Meds, Mind, Body Benefits. Two immune proteins found to control HIV infection... Meds, Mind, Body Benefits Questions About Treatment Side Effects Insurance, Benefits Programs HIV Mental Health HIV Lipodystrophy Metabolic Problems Nutrition HIV Research News Studies. Off Topic Forums Off Topic Forum Forums Gatherings. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums. Author Topic: Two immune proteins found to control HIV infection... Two immune proteins found to control HIV infection... Two immune proteins found to control HIV infection by Alan McCord, January 9, 2009. The NIAID research used new technology to watch how CD8s interact with CD4 cells that are infected with HIV in both LTNPs and progressors whose HIV levels were comparably under control below 50 with drugs. In turn, certain CD8s carry out the task of killing those cells infected with HIV, including CD4s. However, by day 6, in the LTNPs mor...
http://forums.poz.com/index.php?topic=25553.msg319517
*  Study Finds HIV Infection Is an Independent Risk Factor for Lung Cancer - TheBodyPRO.com
... Study Finds HIV Infection Is an Independent Risk Factor for Lung Cancer By Warren Tong. May 24, 2012 Simply having HIV is an independent risk factor for lung cancer, according to a recent study from the U.S. They compiled data from 32,794 HIV-infected individuals and 75,750 HIV-uninfected individuals. There were 457 new cases of lung cancer in the HIV-infected group an incidence rate of 1.4% , compared with 614 cases in the HIV-uninfected group an incidence rate of 0.8%. Advertisement After controlling for other risk factors, the researchers calculated the incidence rates in terms of number of person-years at risk. They found that the incidence rate of lung cancer in the HIV-infected group was 204 cases per 100,000 person-years, while the rate for the HIV-uninfected control group was 119 cases per 100,000 person-years. Which means about a 71% higher rate of lung cancer in the HIV-positive group. The percentage of current smokers between the HIV-infected group 48% and HIV-uninfected group 46% was similar....
http://thebodypro.com/content/67293/study-finds-hiv-infection-is-an-independent-risk-f.html
*  Matched case–control study to evaluate risk factors for hyperlactataemia in HIV patients on antire
Matched case control study to evaluate risk factors for hyperlactataemia in HIV patients on antiretroviral therapy - Datta - 2003 - HIV Medicine - Wiley Online Library. HIV Medicine. JOURNAL MENU Journal Home FIND ISSUES Current Issue. All Issues FIND ARTICLES Early View. Wiley Job Network. You have free access to this content Matched case control study to evaluate risk factors for hyperlactataemia in HIV patients on antiretroviral therapy. D Datta, G Moyle, S Mandalia and B Gazzard Article first published online: 3 OCT 2003 DOI: 10.1046/j.1468-1293.2003.00164.x. HIV Medicine Volume 4, Issue 4, pages 311 314, October 2003. Additional Information How to Cite Datta, D., Moyle, G., Mandalia, S. 2003, Matched case control study to evaluate risk factors for hyperlactataemia in HIV patients on antiretroviral therapy. HIV Medicine, 4: 311 314. E-mail: dattauk@yahoo.co.uk. Publication History Issue published online: 3 OCT 2003 Article first published online: 3 OCT 2003 Received: 9 January 2003, accepted 1 May 2003. S...
http://onlinelibrary.wiley.com/doi/10.1046/j.1468-1293.2003.00164.x/abstract
*  The role of cost-effectiveness analysis in assessing HIV-prevention interventions. Building communit
... y and culture are essential to successful HIV prevention for gay and bisexual men. The role of cost-effectiveness analysis in assessing HIV-prevention interventions Article Abstract: Three HIV-prevention interventions are evaluated using simple cost-effectiveness techniques. The main advantage of using cost-effectiveness to assess HIV-prevention strategies is its ability to use data to achieve public health goals. Policy makers can use cost-effectiveness analysis to distribute prevention resources among populations, based on differences in HIV incidence, program costs and effectiveness of interventions. H Publisher: University Publishing Group Publication Name: AIDS & Public Policy Journal Subject: Law ISSN: 0887-3852 Year: 1997. Comment about this article or add new information about this topic: Public Comment:  50-4000 characters. Building community and culture are essential to successful HIV prevention for gay and bisexual men Article Abstract: The main problem in preventing the spread of HIV in ga...
http://readabstracts.com/Law/The-role-of-cost-effectiveness-analysis-in-assessing-HIV-prevention-interventions.html
*  A Wiznia
... add/edit. You are here: Scientific Experts USA Wiznia A Wiznia. Research Topics hiv fusion inhibitors nelfinavir stavudine puerto rico nevirapine ritonavir hiv envelope protein gp41 anti retroviral agents hiv antibodies continental population groups reverse transcriptase inhibitors ethnic groups hiv infections anti hiv agents viral rna peptide fragments combination drug therapy viral load electric impedance body composition cytokines cd4 lymphocyte count anthropometry lipids hiv. A Wiznia Summary Country: USA. Publications Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children Jacobo Abadi Division of Infectious Diseases, Department of Pediatrics, Jacobi Medical Center and Albert Einstein College of Medicine, 1400 Pelham Parkway, Bronx, NY, USA J Acquir Immune Defic Syndr 41:298-303. 2006 Combination nucleoside analog reverse transcriptase inhibitor s plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-exper...
http://labome.org/expert/usa/wiznia/a-wiznia-732040.html
*  Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth - No Study Results Posted -
... ClinicalTrials.gov. Skip to Main Content. A service of the U.S. National Institutes of Health Example: "Heart attack" AND "Los Angeles" Search for studies:. Advanced Search. Help. Studies by Topic. Glossary. Find Studies. Basic Search. Advanced Search. See Studies by Topic. See Studies on Map. How to Search. How to Use Search Results. How to Find Results of Studies. How to Read a Study Record. About Clinical Studies. Learn About Clinical Studies. Other Sites About Clinical Studies. Glossary of Common Site Terms. Submit Studies. Why Should I Register and Submit Results. FDAAA 801 Requirements. How to Apply for an Account. How to Register Your Study. How to Edit Your Study Record. How to Submit Your Results. Frequently Asked Questions. Support Materials. Training Materials. Resources. Selected Publications. Clinical Alerts and Advisories. RSS Feeds. Trends, Charts, and Maps. Downloading Content for Analysis. About This Site. ClinicalTrials.gov Background. About the Results Database. History, Policies, and ...
https://clinicaltrials.gov/ct2/show/results/NCT00102960
*  Asymptomatic HIV infectionAsymptomatic HIV infection
 Asymptomatic HIV infection. Asymptomatic HIV infection. Main Number: 314-434-1500. Emergency Dept: 314-205-6990. Patient Billing: 888-924-9200. Home. About Us. Services. Patients & Visitors. Health Tools. Classes & Events. Donate & Volunteer. Physicians & Employees. Careers. Contact Us History Mission Locations & Directions Quality Reports Annual Reports Honors & Awards Community Health Needs Assessment Newsroom Brain & Spine Cancer Heart Maternity Orthopedics Pulmonary Sleep Medicine Urgent Care Women's Services All Services Locations & Directions Find a Physician Tour St. Luke's Patient & Visitor Information Contact Us Payment Options Financial Assistance Send a Card Mammogram Appointments My Personal Health. my stlukes. Spirit of Women Health Information & Tools Clinical Trials Health Risk Assessments Employer Programs - Passport to Wellness Classes & Events Spirit of Women Giving Opportunities Volunteer For Physicians Remote Access Medical Residency Information Pharmacy Residency Information Physician C...
http://stlukes-stl.com/health-content/mens/2/9500.htm
*  HIV Prevention
... Main Navigation Skip navigation. Health. Public Health and Safety » HIV/STD » HIV Prevention. HIV Prevention. HIV is the virus that can lead to Acquired Immunodeficiency Virus AIDS. In Montana, 488 people one in 2000 are living with HIV or AIDS. HIV is transmitted through unprotected sexual activity with an infected person, by using infected needles, or through birth or breast milk if the mother is infected. Never share needles or inks for tattoos, ear piercing or body piercing. Counseling Testing Referrals Report 2014 HIV Prevention Community Planning Montana s HIV prevention community planning process is structured for the purpose of meeting the goals for HIV Prevention Community Planning as described in the 2003-2008 HIV Prevention Community Planning Guidance. Goal One Community planning supports broad-based community participation in HIV prevention planning. Goal Two - Community planning identifies priority HIV prevention needs a set of priority target populations and interventions for each identifie...
http://dphhs.mt.gov/publichealth/hivstd/hivprevention
*  Wide US Study Finds 16% With Newly Diagnosed HIV Carry Resistant Virus
... Conference Reports for NATAP. 20th Conference on Retroviruses and Opportunistic Infections Atlanta, GA March 3 - 6, 2013. Back  . Wide US Study Finds 16% With Newly Diagnosed HIV Carry Resistant Virus. . 20th Conference on Retroviruses and Opportunistic Infections, March 3-6, 2013, Atlanta Mark Mascolini Just over 16% of US residents newly diagnosed with HIV infection in 10 metropolitan areas or states carried antiretroviral-resistant virus, according to a CDC study spanning the years 2007 to 2010. The survey confirmed a continuing climb in prevalence of transmitted nonnucleoside-related mutations. Transmitted antiretroviral resistance that goes undetected can jeopardize response to first-line therapy if that regimen includes drugs compromised by resistant virus. The World Health Organization believes prevalence of transmitted drug resistance TDR stands between 10% and 17% in the United States, Europe, Australia, and Japan. A 2006 report by the Adolescent Medicine Trials Network for HIV/AIDS Interven...
http://natap.org/2013/CROI/croi_25.htm
*  P01-01. The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive
The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive to Antiretroviral Therapy. The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive to Antiretroviral Therapy. HMS Scholarly Articles View Item. The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive to Antiretroviral Therapy. The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive to Antiretroviral Therapy. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy. The aim of this study is to elucidate these pathways by characterizing the genome-wide transcriptional signature expressed by whole blood during early AHI. Methods: Longitudinal whole blood samples from ART treated and untreated patients from both the United States n = 16 and Africa n = 16 were collected at study enrollment and weeks 1, 2, 4, 12, and 24. The activity of transcriptional module...
http://dash.harvard.edu/handle/1/4872637
*  Impact of HIV Exposure on Health Outcomes in HIV-Negative In... : JAIDS Journal of Acquired Immun
Text sizing: A. 182-189 entitled “Impact of HIV Exposure on Health Outcomes in HIV-Negative Infants Born to HIV-Positive Mothers in Sub-Saharan Africa,” there is an error in the methods section. Back to Top. Back to Top. Article Outline Study Procedures This study was a prospective, observational cohort study comparing 2 groups of children: those born to HIV-positive women and those born to HIV-negative women. HIV DNA-PCR–negative infants born to HIV-positive mothers were assigned to the ENI group, and infants born to HIV-negative mothers were considered UE. Article Outline RESULTS Study Population Between August 2008 and June 2009,158 HIV-positive mothers and 160 HIV-negative mothers and their children were enrolled. 42 Although it is known that anemia in children is associated with increased morbidity and mortality, 43 the clinical impact of reduced hematocrit levels in ENIC is still unclear. Children born to HIV-positive mothers with CD4 200 cells per microliter are more likely to have a poor birth outcome...
http://journals.lww.com/jaids/Fulltext/2014/02010/Impact_of_HIV_Exposure_on_Health_Outcomes_in.8.aspx
*  Antiretroviral regimen associated with less virological failure among HIV-infected children
... April 30, 2013 in Medicine Health / HIV & AIDS Elizabeth D. Lowenthal, M.D., M.S.C.E., of the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, and colleagues conducted a study to determine whether there was a difference in time to virological failure between HIV-infected children initiating nevirapine vs. efavirenz-based antiretroviral treatment in Botswana. "More than 2 million children worldwide are infected with human immunodeficiency virus HIV, approximately 90 percent of whom live in sub-Saharan Africa," according to background information in the article. "Worldwide, the nonnucleoside reverse transcriptase inhibitors NNRTIs efavirenz and nevirapine are commonly used in first-line antiretroviral regimens in both adults and children with HIV infection. Data on the comparative effectiveness of these medications in children are limited. … Most countries favor nevirapine-based regimens for the majority of children due to perceived comparable effectiveness at...
http://medicalxpress.com/print286534739.html
*  P01-01. The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive
The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive to Antiretroviral Therapy. The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive to Antiretroviral Therapy. DASH Home. HMS Scholarly Articles View Item. The Blood Transcriptional Response to Early Acute HIV Infection is Transient and Responsive to Antiretroviral Therapy. Show simple item record. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. dc.contributor.author. Letvin, Norman Lee. dc.contributor.author. dc.contributor.author. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy. The aim of this study is to elucidate these ...
http://dash.harvard.edu/handle/1/4872637?show=full
*  Women, Children, and HIV
... About UCSF. Search UCSF. UCSF Medical Center. Search Web site. Search. Women, Children, and HIV. Resources for prevention and treatment. http://womenchildrenhiv.org. HIV Resource Library. Training Course. News. Resources on the prevention and treatment of HIV infection in women and children targeted at health workers, program managers, and policy makers in resource-limited settings. New in the Library. Children and Youth Growing Up with HIV Infection in Sub-Saharan Africa: Implications for Health Service Delivery Elsevier. National Guidelines on the Use of Antiretroviral Therapy for HIV Prevention and Treatment Ministry of Health, Lesotho. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States U.S. Tables on Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States U.S. Preventing Perinatal ...
http://womenchildrenhiv.org/
*  Women, Children, and HIV
... About UCSF. Search UCSF. UCSF Medical Center. Search Web site. Search. Women, Children, and HIV. Resources for prevention and treatment. http://womenchildrenhiv.org. HIV Resource Library. Training Course. News. Resources on the prevention and treatment of HIV infection in women and children targeted at health workers, program managers, and policy makers in resource-limited settings. New in the Library. Children and Youth Growing Up with HIV Infection in Sub-Saharan Africa: Implications for Health Service Delivery Elsevier. National Guidelines on the Use of Antiretroviral Therapy for HIV Prevention and Treatment Ministry of Health, Lesotho. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States U.S. Tables on Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States U.S. Preventing Perinatal ...
http://womenchildrenhiv.org/wchiv?page=wx-topic&topic=pp&txid=pp
*  Search of: " August 25, 2009":" September 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] - List
Search of: August 25, 2009 : September 24, 2009 AND HIV - List Results - ClinicalTrials.gov. About Clinical Studies. Terms and Conditions. 41 studies found for : August 25, 2009 : September 24, 2009 AND HIV Modify this search. Subscribe to RSS Create an RSS feed from your search for: August 25, 2009 : September 24, 2009 AND HIV Need help. Download Download the search results for: August 25, 2009 : September 24, 2009 AND HIV 41 records Need help. See Downloading Content for Analysis Number of Studies:. Download Content: Download All Study Fields as XML Download All Study and Results Fields as XML Download Selected Fields:. Intervention. Exclude studies with Unknown status. Rank Status Study 1 Completed Profile of HIV Seropositive Patients. 3 Completed Prevalence of Sexually Transmitted Infections STIs in HIV-infected Patients. Conditions: HIV Infections; Neisseria Gonorrhoeae; Chlamydia Trachomatis; Herpes Simplex. Interventions: Drug: Lopinavir/Ritonavir plus Lamivudine/Zidovudine; Drug: Efavirenz plus Lamivu...
https://clinicaltrials.gov/ct2/results?term=" August 25, 2009":" September 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
*  WHO | Universal access to HIV/AIDS prevention, treatment and care
Universal access to HIV/AIDS prevention, treatment and care. Access Home Alt+0. Navigation Alt+1. Content Alt+2. Search Search the WHO .int site. Navigation Home. Health topics. Data. Media centre. Countries. Governance. Youtube. Twitter. Facebook. Google +. iTunes. Play Store. HIV/AIDS. HIV News and events Topics Publications Data and statistics About us. Universal access to HIV/AIDS prevention, treatment and care. The HIV epidemic remains a major global public health challenge, with more than 34 million people living with HIV worldwide. In 2011 alone, 2.2 million people were newly infected with HIV and 1.7 million people died of AIDS. The WHO, along with UNICEF and UNAIDS Secretariat, has been issuing annual "Towards Universal Access" progress reports, monitoring key components of the worldwide health sector response to HIV, since 2006, when UN Member States committed to universal access to HIV prevention, treatment, care and support by 2010. Latest updates. June 2011 Global health sector strategy on HIV/AI...
http://who.int/hiv/topics/universalaccess/en/
*  WHO | Antiretroviral therapy for HIV infection in infants and children
Antiretroviral therapy for HIV infection in infants and children. Access Home Alt+0. Navigation Alt+1. Content Alt+2. Advanced search. Health topics. Data. Media centre. Publications. Countries. English. Twitter. Facebook. Google +. Play Store. HIV/AIDS. HIV News and events Topics Publications Data and statistics About us. Antiretroviral therapy for HIV infection in infants and children Recommendations for a public health approach: 2010 revision. Share Email Twitter Facebook Google Delicious LinkedIn. Annex E: pdf, 360kb Prescribing information and weight-based dosing of available ARV formulations for infants and children. Overview These treatment guidelines serve as a framework for selecting the most potent and feasible first-line and second-line ART regimens for the care of HIV-infected infants and children. These guidelines address the diagnosis of HIV infection and consider ART in different situations, e.g. where infants and children are coinfected with HIV and TB, or have been exposed to ARVs, either for...
http://who.int/hiv/pub/paediatric/infants2010/en/
*  Early HIV symptoms: What are they? - Mayo Clinic
Early HIV symptoms: What are they. - Mayo Clinic. Diseases and Conditions HIV/AIDS. When do early HIV symptoms first appear. Answers from James M. Steckelberg, M.D. Early HIV symptoms usually occur within a month or two after infection and are often like a bad case of the flu. In many people, early HIV signs and symptoms include:. Fever Headache Fatigue Swollen lymph glands Rash These early HIV symptoms are called acute retroviral syndrome or primary HIV infection and are the body's natural response. Symptoms, if they appear at all, usually disappear within a week to a month and are often mistaken for those of another viral infection. During this period, you are very infectious. More-persistent or more-severe symptoms of HIV infection may not appear for several years after the initial infection. The symptoms that indicate an early HIV infection are extremely common. Often, you can't tell them apart from symptoms of another viral infection. If you're concerned that you might have been exposed to HIV, talk to y...
http://mayoclinic.org/diseases-conditions/hiv-aids/expert-answers/early-hiv-symptoms/FAQ-20058415?p=1
*  Effect of hepatitis C coinfection on discontinuation and mod... : AIDS
Top Cited Articles. Text sizing: A. Objectives: To estimate the effect of hepatitis C HCV coinfection on time to first occurrence of either discontinuation or modification of initial HAART among previously antiretroviral therapy-naive HIV-infected patients. However, the duration of an initial HAART regimen may be relatively short in routine clinical care, with the most common reasons cited for discontinuation or modification being antiretroviral drug-associated intolerance or toxicity. This study of an observational HIV clinical cohort contrasted HIV/HCV-coinfected patients with HIV-infected patients with respect to time to the first occurrence of either discontinuation or modification of an initial HAART regimen and examined the reasons for initial HAART discontinuation or modification. Article Outline Reasons for HAART discontinuation or modification During follow-up, 104 patients discontinued and 91 patients modified their initial HAART regimen, where 150 65% HIV-infected patients discontinued or modified ...
http://journals.lww.com/aidsonline/Fulltext/2006/02280/Effect_of_hepatitis_C_coinfection_on.11.aspx

Management of HIV/AIDS: The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs in an attempt to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle.HIV-positive people: HIV-positive people are people who have the human immunodeficiency virus HIV, the agent of the currently incurable disease AIDS.Vpx: Vpx is a virion-associated protein encoded by human immunodeficiency virus type 2 HIV-2 and most simian immunodeficiency virus (SIV) strains, but that is absent from HIV-1. It is similar in structure to the protein Vpr that is carried by SIV and HIV-2 as well as HIV-1.Adult-onset immunodeficiency syndrome: Adult-onset immunodeficiency syndrome is a provisional name for a newly diagnosed immunodeficiency illness. The name is proposed in the first public study to identify the syndrome.Conference on Retroviruses and Opportunistic Infections: The Conference on Retroviruses and Opportunistic Infections (CROI) is an annual scientific meeting devoted to the understanding, prevention and treatment of HIV/AIDS and the opportunistic infections associated with AIDS. Thousands of leading researchers and clinicians from around the world convene in a different location in North America each year for the Conference.Disinhibition: In psychology, disinhibition is a lack of restraint manifested in disregard for social conventions, impulsivity, and poor risk assessment. Disinhibition affects motor, instinctual, emotional, cognitive, and perceptual aspects with signs and symptoms similar to the diagnostic criteria for mania.Statnamic load test: The Statnamic load test is a type of test for assessing the load carrying capacity of deep foundations which is faster and less expensive than the static load test. The Statnamic test was conceived in 1985, with the first prototype tests carried out in 1988 through collaboration between Berminghammer Foundation Equipment of Canada and TNO Building Research of the Netherlands (Middendorp et al.HIV/AIDS in South African townships: South Africa’s HIV/AIDS epidemic, which is among the most severe in the world, is concentrated in its townships, where many black South Africans live due to the lingering effects of the Group Areas Act. A 2010 study revealed that HIV/AIDS infection in South Africa is distinctly divided along racial lines: 13.QRISK: QRISK2 (the most recent version of QRISK) is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial fibrillation, diabetes mellitus, and antihypertensive treatment.Cognitive effects of HIVControlling Vice: Regulating Brothel Prostitution in St. Paul, 1865-1883: Controlling Vice is a book by Minnesotan author Joel Best, published in 1998. It is the story of the strategies that the Minnesota police officers enforced in attempts to regulate prostitution in the late nineteenth century.Zimbabwe Congress of Trade Unions: The Zimbabwe Congress of Trade Unions is the primary trade union federation in Zimbabwe. The general secretary of ZCTU is Wellington Chibebe and the president is Lovemore Matombo.Protease inhibitor (pharmacology): Protease inhibitors (PIs) are a class of antiviral drugs that are widely used to treat HIV/AIDS and hepatitis caused by hepatitis C virus. Protease inhibitors prevent viral replication by selectively binding to viral proteases (e.LifeStyles Condoms: LifeStyles Condoms is a brand of condom made by the Australian company Ansell Limited, previously known as Pacific Dunlop Limited.Prescott Townsend: Prescott Townsend (June 24, 1894 – May 23, 1973) was an American gay rights activist.Makerere University School of MedicineHistory of syphilis: The history of syphilis has been well studied, but the exact origin of syphilis is unknown. There are two primary hypotheses: one proposes that syphilis was carried to Europe from the Americas by the crew of Christopher Columbus, the other proposes that syphilis previously existed in Europe but went unrecognized.Envelope glycoprotein GP120: Envelope glycoprotein GP120 (or gp120) is a glycoprotein exposed on the surface of the HIV envelope. The 120 in its name comes from its molecular weight of 120 kDa.Karonga District: right|115px|Location of Karonga District in MalawiList of Parliamentary constituencies in Kent: The ceremonial county of Kent,Intact America: Intact America is a registered non-governmental Intactivist (pro-intact or anti-infant circumcision) organization created in 2008 to advance the view that the circumcision of non-consenting minors is unethical and medically unnecessary, and therefore should be abandoned. They also claim that circumcision reduces sexual sensation in males and that it is a violation of modern bio-ethical standards to forcibly remove erogenous tissue from children.Behavior change (public health): Behavior change is a central objective in public health interventions,WHO 2002: World Health Report 2002 - Reducing Risks, Promoting Healthy Life Accessed Feb 2015 http://www.who.CCR5 receptor antagonist: CCR5 receptor antagonists are a class of small molecules that antagonize the CCR5 receptor. The C-C motif chemokine receptor CCR5 is involved in the process by which HIV, the virus that causes AIDS, enters cells.Incidence (epidemiology): Incidence is a measure of the probability of occurrence of a given medical condition in a population within a specified period of time. Although sometimes loosely expressed simply as the number of new cases during some time period, it is better expressed as a proportion or a rate with a denominator.Prenatal nutrition: Nutrition and weight management before and during :pregnancy has a profound effect on the development of infants. This is a rather critical time for healthy fetal development as infants rely heavily on maternal stores and nutrient for optimal growth and health outcome later in life.Proportional reporting ratio: The proportional reporting ratio (PRR) is a statistic that is used to summarize the extent to which a particular adverse event is reported for individuals taking a specific drug, compared to the frequency at which the same adverse event is reported for patients taking some other drug (or who are taking any drug in a specified class of drugs). The PRR will typically be calculated using a surveillance database in which reports of adverse events from a variety of drugs are recorded.Tuberculosis managementSubstance-related disorderHinduism in Zambia: Zambia is home to 25,000 Hindus.as reported by Hinduism Today, 2003 Hinduism is the third largest religion in Zambia.Cancer screeningFederal institutions of Tanzania: This is a list of the federal institutions of Tanzania.BerEp4: BerEp4 is a histologic stain used to aid in the diagnosis of basal cell carcinomaKeliximabList of people with hepatitis C: The infectious disease hepatitis C is caused by the hepatitis C virus (HCV), which affects the liver and is transmitted by blood-to-blood contact, or by exposure to another person's infected blood. The infection is often asymptomatic, but chronic infection can cause inflammation of the liver (chronic hepatitis).Stateville Penitentiary Malaria Study: The Stateville Penitentiary malaria study was a controlled study of the effects of malaria on the prisoners of Stateville Penitentiary near Joliet, Illinois in the 1940s. The study was conducted by the Department of Medicine at the University of Chicago in conjunction with the United States Army and the State Department.Tamil Nadu Dr. M.G.R. Medical UniversityKenya Pipeline CompanyThe Complete Stevie Wonder: The Complete Stevie Wonder is a digital compilation featuring the work of Stevie Wonder. Released a week before the physical release of A Time to Love, the set comprises almost all of Wonder's officially released material, including single mixes, extended versions, remixes, and Workout Stevie Workout, a 1963 album which was shelved and replaced by With A Song In My Heart.India–Rwanda relations: Indo-Rwandan relations are the foreign relations between the Republic of India and the Republic of Rwanda. India is represented in Rwanda through its Honorary Consulate in Kigali.Tumor progression: Tumor progression is the third and last phase in tumor development. This phase is characterised by increased growth speed and invasiveness of the tumor cells.Resistance mutation: A resistance mutation is a point mutations in virus genes that allow the virus to become resistant to treatment with a particular antiviral drug. The term was first used in the management of HIV, the first virus in which genome sequencing was routinely used to look for drug resistance.List of bus routes in Brooklyn: The Metropolitan Transportation Authority (MTA) operates a number of bus routes in Brooklyn, New York, United States; one minor route is privately operated under a city franchise. Many of them are the direct descendants of streetcar lines (see list of streetcar lines in Brooklyn); the ones that started out as bus routes were almost all operated by the Brooklyn Bus Corporation, a subsidiary of the Brooklyn–Manhattan Transit Corporation, until the New York City Board of Transportation took over on June 5, 1940.MIM Pan-African Malaria Conference 2009Temporal analysis of products: Temporal Analysis of Products (TAP), (TAP-2), (TAP-3) is an experimental technique for studyingElvitegravir/cobicistat/emtricitabine/tenofovirTuberculosis radiology: Radiology is used in the diagnosis of tuberculosis.Natural transfer: The natural transfer (hypothesis or theory), in reference to the HIV/AIDS pandemic, states that humans first received HIV by contact with primates, presumably from a fight with a Chimpanzee during hunting or consumption of primate meat, and became contaminated with simian immunodeficiency virus (SIV). According to the 'Hunter Theory', the virus was transmitted from a chimpanzee to a human when a bushmeat hunter was bitten or cut while hunting or butchering an animal.Crack cocaine: Crack cocaine is the freebase form of cocaine that can be smoked. It may also be termed rock, work, hard, iron, cavvy, base, but is most commonly known as just crack; the Manual of Adolescent Substance Abuse Treatment calls it the most addictive form of cocaine.Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors: Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors (NRTIs and NtRTIs) began in the 1980s when the AIDS epidemic hit Western societies. NRTIs inhibit the reverse transcriptase (RT), an enzyme that controls the replication of the genetic material of the human immunodeficiency virus (HIV).

(1/30267) Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.

A key question in understanding the status of the immune system in HIV-1 infection is whether the adult thymus contributes to reconstitution of peripheral T lymphocytes. We analyzed the thymus in adult patients who died of HIV-1 infection. In addition, we studied the clinical course of HIV-1 infection in three patients thymectomized for myasthenia gravis and determined the effect of antiretroviral therapy on CD4(+) T cells. We found that five of seven patients had thymus tissue at autopsy and that all thymuses identified had inflammatory infiltrates surrounding lymphodepleted thymic epithelium. Two of seven patients also had areas of thymopoiesis; one of these patients had peripheral blood CD4(+) T-cell levels of <50/mm3 for 51 months prior to death. Of three thymectomized patients, one rapidly progressed to AIDS, one progressed to AIDS over seven years (normal progressor), whereas the third remains asymptomatic at least seven years after seroconversion. Both latter patients had rises in peripheral blood CD4(+) T cells after antiretroviral therapy. Most patients who died of complications of HIV-1 infection did not have functional thymus tissue, and when present, thymopoiesis did not prevent prolonged lymphopenia. Thymectomy before HIV-1 infection did not preclude either peripheral CD4(+) T-cell rises or clinical responses after antiretroviral therapy.  (+info)

(2/30267) High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.

Intracellular immunization, an antiviral gene therapy approach based on the introduction of DNA into cells to stably express molecules for the inhibition of viral gene expression and replication, has been suggested for inhibition of HIV infection. Since the Tat and Rev proteins play a critical role in HIV regulation, RNA decoys and ribozymes of these sequences have potential as therapeutic molecular inhibitors. In the present study, we have generated several anti-HIV molecules; a tat-ribozyme, RRE, RWZ6 and TAR decoys and combinations of decoys, and tested them for inhibition of HIV-1 replication in vitro. We used T cell specific CD2 gene elements and regulatory the HIV inducible promoter to direct high level expression and a 3' UTR sequence for mRNA stabilization. We show that HIV replication was most strongly inhibited with the combination TAR + RRE decoy when compared with the single decoys or the tat-ribozyme. We also show that the Tat-inducible HIV promoter directs a higher level of steady-state transcription of decoys and inhibitors and that higher levels of expression directly relate to increased levels of inhibition of HIV infection. Furthermore, a stabilization of the 3' end of TAR + RRE inhibitor transcripts using a beta-globin 3' UTR sequence leads to an additional 15-fold increase in steady-state RNA levels. This cassette when used to express the best combination decoy inhibitor TAR + RRE, yields high level HIV inhibition for greater than 3 weeks. Taken together, both optimization for high level expression of molecular inhibitors and use of combinations of inhibitors suggest better therapeutic application in limiting the spread of HIV.  (+info)

(3/30267) Tuberculosis outbreaks in prison housing units for HIV-infected inmates--California, 1995-1996.

During 1995-1996, staff from the California departments of corrections and health services and local health departments investigated two outbreaks of drug-susceptible tuberculosis (TB). The outbreaks occurred in two state correctional institutions with dedicated HIV housing units. In each outbreak, all cases were linked by IS6110-based DNA fingerprinting of Mycobacterium tuberculosis isolates. This report describes the investigations of both outbreaks; the findings indicated that M. tuberculosis can spread rapidly among HIV-infected inmates and be transmitted to their visitors and prison employees, with secondary spread to the community.  (+info)

(4/30267) A review of statistical methods for estimating the risk of vertical human immunodeficiency virus transmission.

BACKGROUND: Estimation of the risk of vertical transmission of human immunodeficiency virus (HIV) has been complicated by the lack of a reliable diagnostic test for paediatric HIV infection. METHODS: A literature search was conducted to identify all statistical methods that have been used to estimate HIV vertical transmission risk. Although the focus of this article is the analysis of birth cohort studies, ad hoc studies are also reviewed. CONCLUSIONS: The standard method for estimating HIV vertical transmission risk is biased and inefficient. Various alternative analytical approaches have been proposed but all involve simplifying assumptions and some are difficult to implement. However, early diagnosis/exclusion of infection is now possible because of improvements in polymerase chain reaction technology and complex estimation methods should no longer be required. The best way to analyse studies conducted in breastfeeding populations is still unclear and deserves attention in view of the many intervention studies being planned or conducted in developing countries.  (+info)

(5/30267) Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland. MRC Collaborative Study of women with HIV.

BACKGROUND: Clinical experience suggests many women with HIV infection have experienced no other sexually transmitted diseases (STD). Our objective was to test the hypothesis that a substantial proportion of women with HIV infection in the United Kingdom and Ireland have experienced no other diagnosed STD and to describe the demographic, clinical and social factors associated with the occurrence of other STD in a cohort of HIV infected women. METHOD: Analysis of cross-sectional baseline data from a prospective study of 505 women with diagnosed HIV infection. The setting was 15 HIV treatment centres in the United Kingdom and Ireland. The main outcome measures were occurrence of other STD diagnosed for the first time before and after HIV diagnosis. Data were obtained from interview with women and clinic notes. We particularly focused on occurrence of gonorrhoea, chlamydia and trichomoniasis after HIV diagnosis, as these are the STD most likely to reflect recent unprotected sexual intercourse. RESULTS: The women were mainly infected via heterosexual sex (n = 304), and injection drug use (n = 174). 151 were black Africans. A total of 250 (49.5%) women reported never having been diagnosed with an STD apart from HIV, 255 (50.5%) women had ever experienced an STD besides HIV, including 109 (21.6%) who had their first other STD diagnosed after HIV. Twenty-five (5%) women reported having had chlamydia, gonorrhoea or trichomoniasis diagnosed for the first time after HIV diagnosis, possibly reflecting unprotected sexual intercourse since HIV diagnosis. In all 301 (60%) women reported having had sex with a man in the 6 months prior to entry to the study. Of these, 168 (58%) reported using condoms 'always', 66(23%) 'sometimes' and 56 (19%) 'never'. CONCLUSIONS: Half the women in this study reported having never experienced any other diagnosed STD besides HIV. However, after HIV diagnosis most women remain sexually active and at least 5% had an STD diagnosed which reflect unprotected sexual intercourse.  (+info)

(6/30267) Pregnancy, body weight and human immunodeficiency virus infection in African women: a prospective cohort study in Kigali (Rwanda), 1992-1994. Pregnancy and HIV Study Group (EGE).

OBJECTIVE: To study the relationship between human immunodeficiency virus (HIV) infection and body weight in African women during and after pregnancy. METHODS: A prospective cohort study was initiated at the Centre Hospitalier de Kigali in July 1992. Every woman seen at the antenatal clinic and with a gestational age of <28 weeks was offered HIV-1 antibody testing. Comparable numbers of HIV-infected (HIV+) and uninfected (HIV-) women were recruited. At inclusion, socio-demographic characteristics and self-reported pre-pregnancy weight were recorded; height and weight were measured. Each woman enrolled had a monthly follow-up until 9 months after delivery, with a clinical examination including weighing. Three anthropometric indices were used to answer the study objectives: weight, body mass index (BMI), and pregnancy balance. RESULTS: As of April 1994, 101 HIV+ and 106 HIV- women were followed until 5 months after delivery. Weight and BMI during pregnancy were lower in HIV+ women than in HIV- women. After delivery, weight and BMI gains were significantly lower in HIV+ women. Until 5 months after delivery, the mean weight variation was -2.2 kg (standard deviation [SD] = 5.9 kg) in HIV+ women and +0.2 kg (SD = 6.6 kg) in HIV- women (P = 0.007) in comparison to pre-pregnancy weight. Comparisons of the slopes of the weight curves did not show statistical differences throughout the pregnancy, but it did during the post-partum period (P = 0.02). CONCLUSIONS: Our study suggests that HIV infection could impair nutritional status in pregnant women, especially during the post-partum period. Family planning and maternal and child health services including HIV testing and counselling, should consider a nutritional assessment and intervention programme targeted to HIV+ pregnant women.  (+info)

(7/30267) Short course antiretroviral regimens to reduce maternal transmission of HIV.

 (+info)

(8/30267) Clinical experience and choice of drug therapy for human immunodeficiency virus disease.

To determine if providers experienced in the management of human immunodeficiency virus (HIV) disease preferred different treatment regimens than providers with less experience, we analyzed data from a national survey of primary care providers' preferred regimens for the management of 30 HIV-related medical conditions. We mailed questionnaires to 999 correct addresses of providers in > 20 cities in the United States in May 1996. We received 524 responses (response rate, 52%). We found a statistically significant association between the number of HIV-infected patients cared for by the provider and the likelihood that the provider would report prescribing highly active antiretroviral therapy and multidrug combinations for treatment of opportunistic infections. Providers with few HIV-infected patients were substantially less likely to report using new therapeutic regimens or new diagnostic tools. We concluded that the preferred regimens of experienced providers are more likely to be consistent with the latest information on treatment for HIV disease than are those of less experienced providers.  (+info)


HIV Infections?


How many days or weeks after being infected does a person begin to show symptoms of being HIV positive?  What are the symptoms of HIV?
----------

About three weeks after exposure there could be some presistent cold, night sweats, east infection that wouldnt go away, slight but consistent fever, swolen glands especially those on the neck.

After this is gone, there might be nothing for years and usually people stay healthy for a few years after becoming hiv poz.  The few weeks after exposure simptoms show because that is when the viral load of the hiv virus in the blood is the highest.

However, don't be mistaken that it will show on a test then.

The Elisa test that tests HIV antibodies present in the blood cant detect them for about 4 weeks the least and 6 months the most. It takes some time until antibodies are formed thus there is a need for a 6 months window from exposure to taking the test in order for the results to be conclusive.

I hope this helps!

Best of luck to ya!


HIV infections?


what happens if someone drinks an HIV victims blood? will that person be infected
----------

Probably, i think any blood to blood contact will transmit the disease and some parts of your digestive system have to be semipermeable with your arteries/veins.


If an infected HIV positive patient used a syringe. How long will the infections stay on the syringe?


I heard that HIV infections cannot stay more than five seconds in the air.Is it true?
----------

I wouldn't bet my LIFE on that assumption!


What kind of infections are people with HIV vulnerable to?


It's for a project. Can anyone tell me what infections/diseases people with HIV are vulnerable to catch?
----------

MAC
Tuberculosis (TB)
Salmonellosis
CMV
Herpes
Hepatitis
Epstein Barr
Genital Wart
Molluscum
Candidiasis
Cryptococcus
Histoplasmosis
Pneumonias
-Bacterial
-PCP
Toxoplasmosis
Cryptosporidium
Isosporiasis


I had unprotected sex with a maried woman and she didnt get an orgasm So am i safe from any HIV infections?


i heard that hiv is transmitted from woman if their orgasm mixes with the blood of the man. after having sex she told me that she didnt get any orgasm. she had a kid and also i had unprotected sex with vrgin before and then with that lady. am i prone to any infections. it happened a 30 - 45 day ago. iam really worried since then if she might had any infections. kindly suggest me something as i heard about muscle pains and headaches as symptoms, as i had these problems sometimes as i work out in the gym or after whole day of work.
----------

DUH?


A patient did indeed have HIV infections, but continued to test negative?


A patient did indeed have HIV infections, but tested negative through repeated ELISA testing. No Western Blot tests were ever performed on the patient, because the physician felt no need to order one because the patient was negative for the ELISA. What are some possible explanations for the consistently negative test results?
----------

Three instances of delayed HIV seroconversion occurring in health-care workers have been reported;[10]  in these instances, the health-care workers[11]  tested negative for HIV antibodies greater than 6 months postexposure but were seropositive within 12 months after the exposure.[12]  DNA sequencing confirmed the source of infection in one instance. Two of the delayed seroconversions were associated with simultaneous exposure to hepatitis C virus (HCV). In one case, co-infection was associated with a rapidly fatal HCV disease course; however, it is not known whether HCV directly influences the risk for or course of HIV infection or is a marker for other exposure-related factors.


This person could have also been in the "window period" if he just obtained the virus.


people infected with HIV the virus that causes the disease aids can become unable to fight off infections by o?


people infected with HIV the virus that causes the disease aids can become unable to fight off infections by organism that normally do not harm people why is it so?
anyone know??
----------

Human Immunodeficiency Virus to Acquired immune deficiency syndrome. Basically you cannot fight virus' any longer, so even a cold can kill you.


Is Bladder Infections in females HIV symptoms?


I keep getting bladder infections, one after the other, even though I am not sexually active at this time, my last sexual encounter was  five months ago could this be a symptom of being infected with HIV?
----------

Awhh.. i do stuff like that too. I assume way too much. Im 16 and have had five or six UTI's... They suck!! They scare me so bad. But they are never anything serious, and girls get them way more often than guys. Its caused by so many things: tight pants, using tampons, nylon underwear, your diet, etc etc. It also can be caused by having sex. But you haven't had sex recently, so no that is most likely not the cause.
Just drink plentyyyy of water. It sucks, but you'll get through it!